#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-7	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-2	8-13	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-3	14-26	connectivity	_
1-4	27-31	best	_
1-5	32-40	predicts	_
1-6	41-48	alcohol	_
1-7	49-52	use	_
1-8	53-61	severity	_
1-9	62-64	in	_
1-10	65-73	moderate	_
1-11	74-76	to	_
1-12	77-82	heavy	_
1-13	83-90	alcohol	_
1-14	91-96	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-15	97-107	Background	_
1-16	108-110	In	_
1-17	111-114	the	_
1-18	115-121	United	_
1-19	122-128	States	_
1-20	129-130	,	_
1-21	131-133	13	_
1-22	134-135	%	_
1-23	136-138	of	_
1-24	139-145	adults	_
1-25	146-149	are	_
1-26	150-159	estimated	_
1-27	160-162	to	_
1-28	163-167	have	_
1-29	168-175	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
1-30	176-179	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
1-31	180-188	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
1-32	189-190	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
1-33	191-194	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
1-34	195-196	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
1-35	197-198	.	_

2-1	199-203	Most	_
2-2	204-211	studies	_
2-3	212-221	examining	_
2-4	222-225	the	_
2-5	226-238	neurobiology	_
2-6	239-241	of	_
2-7	242-245	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
2-8	246-251	treat	_
2-9	252-263	individuals	_
2-10	264-268	with	_
2-11	269-273	this	_
2-12	274-282	disorder	_
2-13	283-285	as	_
2-14	286-287	a	_
2-15	288-299	homogeneous	_
2-16	300-305	group	_
2-17	306-307	;	_
2-18	308-315	however	_
2-19	316-317	,	_
2-20	318-321	the	_
2-21	322-330	theories	_
2-22	331-333	of	_
2-23	334-337	the	_
2-24	338-352	neurocircuitry	_
2-25	353-355	of	_
2-26	356-359	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
2-27	360-364	call	_
2-28	365-368	for	_
2-29	369-370	a	_
2-30	371-383	quantitative	_
2-31	384-387	and	_
2-32	388-399	dimensional	_
2-33	400-408	approach	_
2-34	409-410	.	_

3-1	411-419	Previous	_
3-2	420-427	imaging	_
3-3	428-435	studies	_
3-4	436-440	find	_
3-5	441-452	differences	_
3-6	453-455	in	_
3-7	456-461	brain	_
3-8	462-471	structure	_
3-9	472-473	,	_
3-10	474-482	function	_
3-11	483-484	,	_
3-12	485-488	and	_
3-13	489-502	resting-state	_
3-14	503-515	connectivity	_
3-15	516-518	in	_
3-16	519-522	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
3-17	523-524	,	_
3-18	525-528	but	_
3-19	529-532	few	_
3-20	533-536	use	_
3-21	537-538	a	_
3-22	539-549	multimodal	_
3-23	550-558	approach	_
3-24	559-561	to	_
3-25	562-572	understand	_
3-26	573-576	the	_
3-27	577-588	association	_
3-28	589-596	between	_
3-29	597-605	severity	_
3-30	606-608	of	_
3-31	609-616	alcohol	_
3-32	617-620	use	_
3-33	621-624	and	_
3-34	625-628	the	_
3-35	629-634	brain	_
3-36	635-646	differences	_
3-37	647-648	.	_

4-1	649-656	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
4-2	657-663	Adults	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
4-3	664-665	(	_
4-4	666-670	ages	_
4-5	671-676	22–60	_
4-6	677-678	)	_
4-7	679-683	with	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge
4-8	684-691	problem	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge
4-9	692-700	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge
4-10	701-709	patterns	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge
4-11	710-711	(	_
4-12	712-713	n	_
4-13	714-715	=	_
4-14	716-718	59	_
4-15	719-720	)	_
4-16	721-730	completed	_
4-17	731-732	a	_
4-18	733-743	behavioral	_
4-19	744-747	and	_
4-20	748-760	neuroimaging	_
4-21	761-769	protocol	_
4-22	770-772	at	_
4-23	773-776	the	_
4-24	777-785	National	_
4-25	786-796	Institutes	_
4-26	797-799	of	_
4-27	800-806	Health	_
4-28	807-808	.	_

5-1	809-816	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
5-2	817-825	severity	_
5-3	826-829	was	_
5-4	830-840	quantified	_
5-5	841-845	with	_
5-6	846-849	the	_
5-7	850-857	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-8	858-861	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-9	862-871	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-10	872-886	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-11	887-891	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-12	892-893	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-13	894-899	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-14	900-901	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
5-15	902-903	.	_

6-1	904-906	In	_
6-2	907-908	a	_
6-3	909-910	3	_
6-4	911-912	T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
6-5	913-916	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
6-6	917-924	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
6-7	925-926	,	_
6-8	927-939	participants	_
6-9	940-949	underwent	_
6-10	950-951	a	_
6-11	952-962	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
6-12	963-966	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
6-13	967-969	as	_
6-14	970-974	well	_
6-15	975-977	as	_
6-16	978-991	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
6-17	992-993	,	_
6-18	994-1002	monetary	_
6-19	1003-1012	incentive	_
6-20	1013-1018	delay	_
6-21	1019-1020	,	_
6-22	1021-1024	and	_
6-23	1025-1029	face	_
6-24	1030-1038	matching	_
6-25	1039-1043	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-26	1044-1049	scans	_
6-27	1050-1051	.	_

7-1	1052-1059	Machine	_
7-2	1060-1068	learning	_
7-3	1069-1072	was	_
7-4	1073-1080	applied	_
7-5	1081-1084	and	_
7-6	1085-1092	trained	_
7-7	1093-1098	using	_
7-8	1099-1102	the	_
7-9	1103-1109	neural	_
7-10	1110-1114	data	_
7-11	1115-1119	from	_
7-12	1120-1123	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
7-13	1124-1132	scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
7-14	1133-1134	.	_

8-1	1135-1138	The	_
8-2	1139-1144	model	_
8-3	1145-1148	was	_
8-4	1149-1155	tested	_
8-5	1156-1159	for	_
8-6	1160-1176	generalizability	_
8-7	1177-1179	in	_
8-8	1180-1181	a	_
8-9	1182-1192	validation	_
8-10	1193-1199	sample	_
8-11	1200-1201	(	_
8-12	1202-1203	n	_
8-13	1204-1205	=	_
8-14	1206-1208	24	_
8-15	1209-1210	)	_
8-16	1211-1212	.	_

9-1	1213-1220	Results	_
9-2	1221-1224	The	_
9-3	1225-1232	resting	_
9-4	1233-1251	state-connectivity	_
9-5	1252-1260	features	_
9-6	1261-1266	model	_
9-7	1267-1271	best	_
9-8	1272-1281	predicted	_
9-9	1282-1285	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
9-10	1286-1294	severity	_
9-11	1295-1297	in	_
9-12	1298-1301	the	_
9-13	1302-1307	naïve	_
9-14	1308-1314	sample	_
9-15	1315-1316	,	_
9-16	1317-1325	compared	_
9-17	1326-1328	to	_
9-18	1329-1333	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
9-19	1334-1338	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
9-20	1339-1340	,	_
9-21	1341-1351	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
9-22	1352-1355	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
9-23	1356-1357	,	_
9-24	1358-1366	combined	_
9-25	1367-1370	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
9-26	1371-1379	features	_
9-27	1380-1381	,	_
9-28	1382-1384	or	_
9-29	1385-1396	demographic	_
9-30	1397-1405	features	_
9-31	1406-1407	.	_

10-1	1408-1415	Network	_
10-2	1416-1428	connectivity	_
10-3	1429-1437	features	_
10-4	1438-1445	between	_
10-5	1446-1454	salience	_
10-6	1455-1462	network	_
10-7	1463-1464	,	_
10-8	1465-1472	default	_
10-9	1473-1477	mode	_
10-10	1478-1485	network	_
10-11	1486-1487	,	_
10-12	1488-1497	executive	_
10-13	1498-1505	control	_
10-14	1506-1513	network	_
10-15	1514-1515	,	_
10-16	1516-1519	and	_
10-17	1520-1527	sensory	_
10-18	1528-1536	networks	_
10-19	1537-1546	explained	_
10-20	1547-1549	33	_
10-21	1550-1551	%	_
10-22	1552-1554	of	_
10-23	1555-1558	the	_
10-24	1559-1567	variance	_
10-25	1568-1578	associated	_
10-26	1579-1583	with	_
10-27	1584-1589	AUDIT	_
10-28	1590-1592	in	_
10-29	1593-1597	this	_
10-30	1598-1603	model	_
10-31	1604-1605	.	_

11-1	1606-1617	Conclusions	_
11-2	1618-1623	These	_
11-3	1624-1632	findings	_
11-4	1633-1641	indicate	_
11-5	1642-1646	that	_
11-6	1647-1650	the	_
11-7	1651-1657	neural	_
11-8	1658-1665	effects	_
11-9	1666-1668	of	_
11-10	1669-1672	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
11-11	1673-1677	vary	_
11-12	1678-1687	according	_
11-13	1688-1690	to	_
11-14	1691-1699	severity	_
11-15	1700-1701	.	_

12-1	1702-1705	Our	_
12-2	1706-1713	results	_
12-3	1714-1723	emphasize	_
12-4	1724-1727	the	_
12-5	1728-1735	utility	_
12-6	1736-1738	of	_
12-7	1739-1746	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
12-8	1747-1752	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
12-9	1753-1757	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
12-10	1758-1760	as	_
12-11	1761-1762	a	_
12-12	1763-1775	neuroimaging	_
12-13	1776-1785	biomarker	_
12-14	1786-1789	for	_
12-15	1790-1802	quantitative	_
12-16	1803-1811	clinical	_
12-17	1812-1822	evaluation	_
12-18	1823-1825	of	_
12-19	1826-1829	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
12-20	1830-1831	.	_

13-1	1832-1842	Highlights	_
13-2	1843-1848	Brain	_
13-3	1849-1857	features	_
13-4	1858-1865	predict	_
13-5	1866-1873	alcohol	_
13-6	1874-1877	use	_
13-7	1878-1886	disorder	_
13-8	1887-1895	severity	_
13-9	1896-1897	.	_

14-1	1898-1905	Resting	_
14-2	1906-1911	state	_
14-3	1912-1917	brain	_
14-4	1918-1930	connectivity	_
14-5	1931-1933	is	_
14-6	1934-1937	the	_
14-7	1938-1942	most	_
14-8	1943-1949	stable	_
14-9	1950-1960	predictive	_
14-10	1961-1968	feature	_
14-11	1969-1972	set	_
14-12	1973-1974	.	_

15-1	1975-1983	Salience	_
15-2	1984-1985	,	_
15-3	1986-1993	default	_
15-4	1994-1998	mode	_
15-5	1999-2000	,	_
15-6	2001-2004	and	_
15-7	2005-2014	executive	_
15-8	2015-2022	control	_
15-9	2023-2031	networks	_
15-10	2032-2039	predict	_
15-11	2040-2047	alcohol	_
15-12	2048-2051	use	_
15-13	2052-2060	severity	_
15-14	2061-2062	.	_

16-1	2063-2072	Differing	_
16-2	2073-2080	imaging	_
16-3	2081-2091	modalities	_
16-4	2092-2098	detect	_
16-5	2099-2105	shared	_
16-6	2106-2109	and	_
16-7	2110-2118	distinct	_
16-8	2119-2126	alcohol	_
16-9	2127-2134	related	_
16-10	2135-2143	features	_
16-11	2144-2145	.	_

17-1	2146-2153	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
17-2	2154-2157	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
17-3	2158-2167	materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
17-4	2168-2180	Participants	_
17-5	2181-2188	Primary	_
17-6	2189-2195	sample	_
17-7	2196-2201	Adult	_
17-8	2202-2205	men	http://maven.renci.org/NeuroBridge/neurobridge#Menopause
17-9	2206-2209	and	_
17-10	2210-2215	women	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
17-11	2216-2220	with	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
17-12	2221-2229	moderate	_
17-13	2230-2232	to	_
17-14	2233-2238	heavy	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
17-15	2239-2246	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
17-16	2247-2250	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
17-17	2251-2252	(	_
17-18	2253-2254	N	_
17-19	2255-2256	=	_
17-20	2257-2259	59	_
17-21	2260-2261	)	_
17-22	2262-2271	completed	_
17-23	2272-2273	a	_
17-24	2274-2286	neuroimaging	_
17-25	2287-2295	protocol	_
17-26	2296-2298	at	_
17-27	2299-2302	the	_
17-28	2303-2311	National	_
17-29	2312-2322	Institutes	_
17-30	2323-2325	of	_
17-31	2326-2333	Alcohol	_
17-32	2334-2339	Abuse	_
17-33	2340-2343	and	_
17-34	2344-2354	Alcoholism	_
17-35	2355-2356	(	_
17-36	2357-2362	NIAAA	_
17-37	2363-2364	)	_
17-38	2365-2366	.	_

18-1	2367-2379	Participants	_
18-2	2380-2384	were	_
18-3	2385-2394	recruited	_
18-4	2395-2399	from	_
18-5	2400-2405	NIAAA	_
18-6	2406-2415	inpatient	_
18-7	2416-2425	treatment	_
18-8	2426-2429	and	_
18-9	2430-2434	from	_
18-10	2435-2438	the	_
18-11	2439-2448	community	_
18-12	2449-2450	(	_
18-13	2451-2454	See	_
18-14	2455-2467	Supplemental	_
18-15	2468-2473	Table	_
18-16	2474-2475	3	_
18-17	2476-2479	for	_
18-18	2480-2483	the	_
18-19	2484-2495	demographic	_
18-20	2496-2504	features	_
18-21	2505-2507	of	_
18-22	2508-2517	inpatient	_
18-23	2518-2521	and	_
18-24	2522-2532	outpatient	_
18-25	2533-2540	samples	_
18-26	2541-2542	)	_
18-27	2543-2544	.	_

19-1	2545-2549	This	_
19-2	2550-2555	study	_
19-3	2556-2559	was	_
19-4	2560-2567	carried	_
19-5	2568-2571	out	_
19-6	2572-2574	in	_
19-7	2575-2585	accordance	_
19-8	2586-2590	with	_
19-9	2591-2594	and	_
19-10	2595-2597	as	_
19-11	2598-2606	approved	_
19-12	2607-2609	by	_
19-13	2610-2613	the	_
19-14	2614-2622	National	_
19-15	2623-2633	Institutes	_
19-16	2634-2636	of	_
19-17	2637-2643	Health	_
19-18	2644-2654	Addictions	_
19-19	2655-2668	Institutional	_
19-20	2669-2675	Review	_
19-21	2676-2681	Board	_
19-22	2682-2683	.	_

20-1	2684-2687	All	_
20-2	2688-2700	participants	_
20-3	2701-2705	gave	_
20-4	2706-2713	written	_
20-5	2714-2715	,	_
20-6	2716-2724	informed	_
20-7	2725-2732	consent	_
20-8	2733-2735	in	_
20-9	2736-2746	accordance	_
20-10	2747-2751	with	_
20-11	2752-2755	the	_
20-12	2756-2767	Declaration	_
20-13	2768-2770	of	_
20-14	2771-2779	Helsinki	_
20-15	2780-2781	.	_

21-1	2782-2785	See	_
21-2	2786-2791	Table	_
21-3	2792-2793	1	_
21-4	2794-2795	(	_
21-5	2796-2797	A	_
21-6	2798-2799	&	_
21-7	2800-2801	C	_
21-8	2802-2803	)	_
21-9	2804-2807	for	_
21-10	2808-2809	a	_
21-11	2810-2821	description	_
21-12	2822-2824	of	_
21-13	2825-2828	the	_
21-14	2829-2835	sample	_
21-15	2836-2848	demographics	_
21-16	2849-2850	.	_

22-1	2851-2860	Exclusion	_
22-2	2861-2869	criteria	_
22-3	2870-2874	were	_
22-4	2875-2877	as	_
22-5	2878-2885	follows	_
22-6	2886-2887	:	_
22-7	2888-2897	currently	_
22-8	2898-2910	experiencing	_
22-9	2911-2921	withdrawal	_
22-10	2922-2926	from	_
22-11	2927-2934	alcohol	_
22-12	2935-2936	,	_
22-13	2937-2941	left	_
22-14	2942-2952	handedness	_
22-15	2953-2954	,	_
22-16	2955-2964	currently	_
22-17	2965-2972	testing	_
22-18	2973-2981	positive	_
22-19	2982-2985	for	_
22-20	2986-2991	drugs	_
22-21	2992-2993	(	_
22-22	2994-2997	THC	_
22-23	2998-2999	,	_
22-24	3000-3007	cocaine	_
22-25	3008-3009	,	_
22-26	3010-3025	methamphetamine	_
22-27	3026-3027	,	_
22-28	3028-3035	opiates	_
22-29	3036-3037	,	_
22-30	3038-3040	or	_
22-31	3041-3055	benzodiazepine	_
22-32	3056-3057	)	_
22-33	3058-3059	,	_
22-34	3060-3062	or	_
22-35	3063-3066	MRI	_
22-36	3067-3082	contraindicated	_
22-37	3083-3084	.	_

23-1	3085-3097	Additionally	_
23-2	3098-3099	,	_
23-3	3100-3112	participants	_
23-4	3113-3117	with	_
23-5	3118-3120	IQ	_
23-6	3121-3122	<	_
23-7	3123-3125	70	_
23-8	3126-3128	or	_
23-9	3129-3132	age	_
23-10	3133-3134	>	_
23-11	3135-3137	60	_
23-12	3138-3142	were	_
23-13	3143-3151	excluded	_
23-14	3152-3156	from	_
23-15	3157-3165	analysis	_
23-16	3166-3167	.	_

24-1	3168-3171	The	_
24-2	3172-3177	final	_
24-3	3178-3184	sample	_
24-4	3185-3193	included	_
24-5	3194-3198	four	_
24-6	3199-3207	subjects	_
24-7	3208-3212	with	_
24-8	3213-3216	one	_
24-9	3217-3225	comorbid	_
24-10	3226-3235	substance	_
24-11	3236-3239	use	_
24-12	3240-3248	disorder	_
24-13	3249-3250	(	_
24-14	3251-3259	cannabis	_
24-15	3260-3265	abuse	_
24-16	3266-3267	,	_
24-17	3268-3272	mild	_
24-18	3273-3281	cannabis	_
24-19	3282-3285	use	_
24-20	3286-3294	disorder	_
24-21	3295-3296	,	_
24-22	3297-3304	cocaine	_
24-23	3305-3310	abuse	_
24-24	3311-3312	,	_
24-25	3313-3316	and	_
24-26	3317-3327	anxiolytic	_
24-27	3328-3338	dependence	_
24-28	3339-3340	)	_
24-29	3341-3342	.	_

25-1	3343-3347	This	_
25-2	3348-3357	sub-group	_
25-3	3358-3359	(	_
25-4	3360-3362	75	_
25-5	3363-3364	%	_
25-6	3365-3369	male	_
25-7	3370-3371	,	_
25-8	3372-3374	50	_
25-9	3375-3376	%	_
25-10	3377-3386	inpatient	_
25-11	3387-3388	)	_
25-12	3389-3392	did	_
25-13	3393-3396	not	_
25-14	3397-3403	differ	_
25-15	3404-3417	significantly	_
25-16	3418-3422	from	_
25-17	3423-3426	the	_
25-18	3427-3434	overall	_
25-19	3435-3441	sample	_
25-20	3442-3444	on	_
25-21	3445-3448	age	_
25-22	3449-3450	,	_
25-23	3451-3453	IQ	_
25-24	3454-3455	,	_
25-25	3456-3461	years	_
25-26	3462-3464	of	_
25-27	3465-3474	education	_
25-28	3475-3476	,	_
25-29	3477-3482	AUDIT	_
25-30	3483-3484	,	_
25-31	3485-3492	average	_
25-32	3493-3499	drinks	_
25-33	3500-3503	per	_
25-34	3504-3507	day	_
25-35	3508-3509	,	_
25-36	3510-3512	or	_
25-37	3513-3523	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
25-38	3524-3528	Test	_
25-39	3529-3531	of	http://maven.renci.org/NeuroBridge/neurobridge#NicotineDependenceRatingScale
25-40	3532-3540	Nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineDependenceRatingScale
25-41	3541-3551	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#NicotineDependenceRatingScale
25-42	3552-3559	smoking	_
25-43	3560-3565	score	_
25-44	3566-3567	.	_

26-1	3568-3578	Validation	_
26-2	3579-3585	sample	_
26-3	3586-3598	Participants	_
26-4	3599-3600	(	_
26-5	3601-3602	n	_
26-6	3603-3604	=	_
26-7	3605-3607	24	_
26-8	3608-3609	)	_
26-9	3610-3614	were	_
26-10	3615-3624	recruited	_
26-11	3625-3628	and	_
26-12	3629-3637	included	_
26-13	3638-3643	based	_
26-14	3644-3646	on	_
26-15	3647-3650	the	_
26-16	3651-3661	procedures	_
26-17	3662-3671	described	_
26-18	3672-3677	above	_
26-19	3678-3679	.	_

27-1	3680-3683	See	_
27-2	3684-3689	Table	_
27-3	3690-3691	1	_
27-4	3692-3693	(	_
27-5	3694-3695	B	_
27-6	3696-3697	&	_
27-7	3698-3699	D	_
27-8	3700-3701	)	_
27-9	3702-3705	for	_
27-10	3706-3707	a	_
27-11	3708-3719	description	_
27-12	3720-3722	of	_
27-13	3723-3729	sample	_
27-14	3730-3742	demographics	_
27-15	3743-3744	.	_

28-1	3745-3755	Behavioral	_
28-2	3756-3760	data	_
28-3	3761-3771	collection	_
28-4	3772-3784	Participants	_
28-5	3785-3794	completed	_
28-6	3795-3796	a	_
28-7	3797-3809	standardized	_
28-8	3810-3819	screening	_
28-9	3820-3829	procedure	_
28-10	3830-3831	,	_
28-11	3832-3841	including	_
28-12	3842-3853	demographic	_
28-13	3854-3855	,	_
28-14	3856-3862	health	_
28-15	3863-3864	,	_
28-16	3865-3868	and	_
28-17	3869-3876	alcohol	_
28-18	3877-3880	use	_
28-19	3881-3892	information	_
28-20	3893-3894	.	_

29-1	3895-3897	We	_
29-2	3898-3907	collected	_
29-3	3908-3911	the	_
29-4	3912-3917	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
29-5	3918-3920	to	_
29-6	3921-3928	measure	_
29-7	3929-3936	problem	_
29-8	3937-3944	alcohol	_
29-9	3945-3948	use	_
29-10	3949-3957	severity	_
29-11	3958-3959	;	_
29-12	3960-3964	when	_
29-13	3965-3967	we	_
29-14	3968-3973	refer	_
29-15	3974-3976	to	_
29-16	3977-3984	alcohol	_
29-17	3985-3988	use	_
29-18	3989-3997	severity	_
29-19	3998-3999	,	_
29-20	4000-4002	we	_
29-21	4003-4006	are	_
29-22	4007-4016	referring	_
29-23	4017-4019	to	_
29-24	4020-4025	score	_
29-25	4026-4028	on	_
29-26	4029-4032	the	_
29-27	4033-4038	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
29-28	4039-4040	,	_
29-29	4041-4047	rather	_
29-30	4048-4052	than	_
29-31	4053-4058	DSM-5	_
29-32	4059-4068	diagnosed	_
29-33	4069-4077	disorder	_
29-34	4078-4086	severity	_
29-35	4087-4088	.	_

30-1	4089-4092	The	_
30-2	4093-4098	AUDIT	_
30-3	4099-4101	is	_
30-4	4102-4103	a	_
30-5	4104-4111	10-item	_
30-6	4112-4123	self-report	_
30-7	4124-4131	measure	_
30-8	4132-4140	covering	_
30-9	4141-4148	alcohol	_
30-10	4149-4160	consumption	_
30-11	4161-4162	,	_
30-12	4163-4171	drinking	_
30-13	4172-4180	behavior	_
30-14	4181-4182	,	_
30-15	4183-4186	and	_
30-16	4187-4202	alcohol-related	_
30-17	4203-4211	problems	_
30-18	4212-4213	.	_

31-1	4214-4218	Each	_
31-2	4219-4223	item	_
31-3	4224-4226	is	_
31-4	4227-4233	scored	_
31-5	4234-4241	between	_
31-6	4242-4243	0	_
31-7	4244-4245	(	_
31-8	4246-4251	least	_
31-9	4252-4258	severe	_
31-10	4259-4260	)	_
31-11	4261-4264	and	_
31-12	4265-4266	4	_
31-13	4267-4268	(	_
31-14	4269-4273	most	_
31-15	4274-4280	severe	_
31-16	4281-4282	)	_
31-17	4283-4284	.	_

32-1	4285-4289	When	_
32-2	4290-4293	the	_
32-3	4294-4299	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
32-4	4300-4302	is	_
32-5	4303-4307	used	_
32-6	4308-4311	for	_
32-7	4312-4321	diagnosis	_
32-8	4322-4323	,	_
32-9	4324-4325	a	_
32-10	4326-4331	score	_
32-11	4332-4334	of	_
32-12	4335-4336	8	_
32-13	4337-4339	or	_
32-14	4340-4345	above	_
32-15	4346-4348	is	_
32-16	4349-4358	suggested	_
32-17	4359-4361	to	_
32-18	4362-4370	indicate	_
32-19	4371-4374	AUD	http://maven.renci.org/NeuroBridge/neurobridge#Audiometer
32-20	4375-4376	.	_

33-1	4377-4384	Average	_
33-2	4385-4391	number	_
33-3	4392-4394	of	_
33-4	4395-4403	consumed	_
33-5	4404-4413	alcoholic	_
33-6	4414-4420	drinks	_
33-7	4421-4424	per	_
33-8	4425-4428	day	_
33-9	4429-4432	was	_
33-10	4433-4442	collected	_
33-11	4443-4448	using	_
33-12	4449-4452	the	_
33-13	4453-4460	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
33-14	4461-4469	Timeline	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
33-15	4470-4476	Follow	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
33-16	4477-4481	Back	_
33-17	4482-4483	,	_
33-18	4484-4489	which	_
33-19	4490-4498	assesses	_
33-20	4499-4507	drinking	_
33-21	4508-4512	over	_
33-22	4513-4516	the	_
33-23	4517-4521	last	_
33-24	4522-4524	90	_
33-25	4525-4529	days	_
33-26	4530-4531	.	_

34-1	4532-4534	We	_
34-2	4535-4539	also	_
34-3	4540-4549	collected	_
34-4	4550-4553	the	_
34-5	4554-4562	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-6	4563-4574	Abbreviated	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-7	4575-4580	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-8	4581-4583	of	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-9	4584-4596	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-10	4597-4599	II	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-11	4600-4601	(	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-12	4602-4606	WASI	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-13	4607-4608	)	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
34-14	4609-4611	to	_
34-15	4612-4618	assess	_
34-16	4619-4621	IQ	_
34-17	4622-4623	.	_

35-1	4624-4627	The	_
35-2	4628-4632	WASI	_
35-3	4633-4635	is	_
35-4	4636-4637	a	_
35-5	4638-4643	short	_
35-6	4644-4648	form	_
35-7	4649-4660	measurement	_
35-8	4661-4663	to	_
35-9	4664-4672	estimate	_
35-10	4673-4685	intelligence	_
35-11	4686-4691	based	_
35-12	4692-4694	on	_
35-13	4695-4707	two-subtests	_
35-14	4708-4709	:	_
35-15	4710-4720	vocabulary	_
35-16	4721-4724	and	_
35-17	4725-4731	matrix	_
35-18	4732-4741	reasoning	_
35-19	4742-4743	.	_

36-1	4744-4747	The	_
36-2	4748-4758	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
36-3	4759-4763	Test	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
36-4	4764-4767	for	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
36-5	4768-4776	Nicotine	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
36-6	4777-4787	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
36-7	4788-4791	was	_
36-8	4792-4801	collected	_
36-9	4802-4804	to	_
36-10	4805-4813	quantify	_
36-11	4814-4820	levels	_
36-12	4821-4823	of	_
36-13	4824-4831	smoking	_
36-14	4832-4833	.	_

37-1	4834-4846	Participants	_
37-2	4847-4851	were	_
37-3	4852-4864	breathalyzed	_
37-4	4865-4867	at	_
37-5	4868-4871	the	_
37-6	4872-4881	beginning	_
37-7	4882-4884	of	_
37-8	4885-4889	each	_
37-9	4890-4895	study	_
37-10	4896-4901	visit	_
37-11	4902-4903	,	_
37-12	4904-4907	and	_
37-13	4908-4912	were	_
37-14	4913-4916	not	_
37-15	4917-4920	run	_
37-16	4921-4925	with	_
37-17	4926-4927	a	_
37-18	4928-4933	blood	_
37-19	4934-4941	alcohol	_
37-20	4942-4947	level	_
37-21	4948-4949	>	_
37-22	4950-4954	0.00	_
37-23	4955-4959	g/dl	_
37-24	4960-4961	.	_

38-1	4962-4966	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-2	4967-4972	tasks	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-3	4973-4981	Monetary	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-4	4982-4991	Incentive	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-5	4992-4997	Delay	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-6	4998-4999	(	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-7	5000-5003	MID	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-8	5004-5005	)	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeDiseaseoftheCentralNervousSystem
38-9	5006-5010	Task	_
38-10	5011-5023	Anticipation	_
38-11	5024-5026	of	_
38-12	5027-5035	monetary	_
38-13	5036-5042	reward	_
38-14	5043-5046	and	_
38-15	5047-5051	loss	_
38-16	5052-5055	was	_
38-17	5056-5064	measured	_
38-18	5065-5074	following	_
38-19	5075-5076	a	_
38-20	5077-5085	modified	_
38-21	5086-5093	version	_
38-22	5094-5096	of	_
38-23	5097-5100	the	_
38-24	5101-5111	procedures	_
38-25	5112-5121	described	_
38-26	5122-5124	in	_
38-27	5125-5126	.	_

39-1	5127-5133	During	_
39-2	5134-5138	this	_
39-3	5139-5143	task	_
39-4	5144-5145	,	_
39-5	5146-5158	participants	_
39-6	5159-5162	saw	_
39-7	5163-5166	cue	_
39-8	5167-5174	symbols	_
39-9	5175-5177	to	_
39-10	5178-5186	indicate	_
39-11	5187-5190	one	_
39-12	5191-5193	of	_
39-13	5194-5198	five	_
39-14	5199-5209	conditions	_
39-15	5210-5211	:	_
39-16	5212-5213	1	_
39-17	5214-5215	)	_
39-18	5216-5219	low	_
39-19	5220-5226	reward	_
39-20	5227-5228	(	_
39-21	5229-5232	win	_
39-22	5233-5234	$	_
39-23	5235-5239	0.20	_
39-24	5240-5241	)	_
39-25	5242-5243	,	_
39-26	5244-5245	2	_
39-27	5246-5247	)	_
39-28	5248-5252	high	_
39-29	5253-5259	reward	_
39-30	5260-5261	(	_
39-31	5262-5265	win	_
39-32	5266-5267	$	_
39-33	5268-5272	1.00	_
39-34	5273-5274	)	_
39-35	5275-5276	,	_
39-36	5277-5278	3	_
39-37	5279-5280	)	_
39-38	5281-5284	low	_
39-39	5285-5289	loss	_
39-40	5290-5291	(	_
39-41	5292-5296	lose	_
39-42	5297-5298	$	_
39-43	5299-5303	0.20	_
39-44	5304-5305	)	_
39-45	5306-5307	,	_
39-46	5308-5309	4	_
39-47	5310-5311	)	_
39-48	5312-5316	high	_
39-49	5317-5321	loss	_
39-50	5322-5323	(	_
39-51	5324-5328	lose	_
39-52	5329-5330	$	_
39-53	5331-5335	1.00	_
39-54	5336-5337	)	_
39-55	5338-5339	,	_
39-56	5340-5343	and	_
39-57	5344-5345	5	_
39-58	5346-5347	)	_
39-59	5348-5355	neutral	_
39-60	5356-5357	(	_
39-61	5358-5360	no	_
39-62	5361-5365	loss	_
39-63	5366-5368	or	_
39-64	5369-5375	reward	_
39-65	5376-5377	)	_
39-66	5378-5379	.	_

40-1	5380-5389	Following	_
40-2	5390-5394	this	_
40-3	5395-5398	cue	_
40-4	5399-5401	at	_
40-5	5402-5403	a	_
40-6	5404-5412	variable	_
40-7	5413-5421	interval	_
40-8	5422-5423	(	_
40-9	5424-5433	2000–2500	_
40-10	5434-5438	msec	_
40-11	5439-5440	)	_
40-12	5441-5442	,	_
40-13	5443-5446	the	_
40-14	5447-5458	participant	_
40-15	5459-5468	responded	_
40-16	5469-5471	to	_
40-17	5472-5473	a	_
40-18	5474-5480	target	_
40-19	5481-5489	stimulus	_
40-20	5490-5494	with	_
40-21	5495-5496	a	_
40-22	5497-5503	button	_
40-23	5504-5509	press	_
40-24	5510-5511	.	_

41-1	5512-5515	For	_
41-2	5516-5522	reward	_
41-3	5523-5533	conditions	_
41-4	5534-5535	,	_
41-5	5536-5548	successfully	_
41-6	5549-5557	pressing	_
41-7	5558-5564	during	_
41-8	5565-5568	the	_
41-9	5569-5575	target	_
41-10	5576-5582	period	_
41-11	5583-5591	resulted	_
41-12	5592-5594	in	_
41-13	5595-5602	receipt	_
41-14	5603-5605	of	_
41-15	5606-5614	monetary	_
41-16	5615-5621	reward	_
41-17	5622-5623	.	_

42-1	5624-5627	For	_
42-2	5628-5632	loss	_
42-3	5633-5643	conditions	_
42-4	5644-5645	,	_
42-5	5646-5653	failing	_
42-6	5654-5656	to	_
42-7	5657-5662	press	_
42-8	5663-5669	during	_
42-9	5670-5673	the	_
42-10	5674-5680	target	_
42-11	5681-5687	period	_
42-12	5688-5696	resulted	_
42-13	5697-5699	in	_
42-14	5700-5704	loss	_
42-15	5705-5707	of	_
42-16	5708-5716	monetary	_
42-17	5717-5723	reward	_
42-18	5724-5725	.	_

43-1	5726-5733	Failure	_
43-2	5734-5736	to	_
43-3	5737-5740	hit	_
43-4	5741-5742	a	_
43-5	5743-5749	reward	_
43-6	5750-5756	target	_
43-7	5757-5758	,	_
43-8	5759-5771	successfully	_
43-9	5772-5779	hitting	_
43-10	5780-5781	a	_
43-11	5782-5786	loss	_
43-12	5787-5793	target	_
43-13	5794-5795	,	_
43-14	5796-5799	and	_
43-15	5800-5803	all	_
43-16	5804-5813	responses	_
43-17	5814-5816	to	_
43-18	5817-5824	neutral	_
43-19	5825-5832	targets	_
43-20	5833-5836	did	_
43-21	5837-5840	not	_
43-22	5841-5847	result	_
43-23	5848-5850	in	_
43-24	5851-5854	any	_
43-25	5855-5863	monetary	_
43-26	5864-5871	outcome	_
43-27	5872-5873	.	_

44-1	5874-5886	Participants	_
44-2	5887-5891	were	_
44-3	5892-5897	given	_
44-4	5898-5906	feedback	_
44-5	5907-5912	after	_
44-6	5913-5920	another	_
44-7	5921-5929	jittered	_
44-8	5930-5935	delay	_
44-9	5936-5938	of	_
44-10	5939-5948	1500–5000	_
44-11	5949-5953	msec	_
44-12	5954-5963	following	_
44-13	5964-5969	their	_
44-14	5970-5976	button	_
44-15	5977-5982	press	_
44-16	5983-5984	.	_

45-1	5985-5990	There	_
45-2	5991-5995	were	_
45-3	5996-5998	17	_
45-4	5999-6005	trials	_
45-5	6006-6009	per	_
45-6	6010-6013	cue	_
45-7	6014-6018	type	_
45-8	6019-6020	.	_

46-1	6021-6025	Face	_
46-2	6026-6034	matching	_
46-3	6035-6039	task	_
46-4	6040-6050	Processing	_
46-5	6051-6053	of	_
46-6	6054-6063	emotional	_
46-7	6064-6069	faces	_
46-8	6070-6073	was	_
46-9	6074-6082	measured	_
46-10	6083-6092	following	_
46-11	6093-6094	a	_
46-12	6095-6103	modified	_
46-13	6104-6111	version	_
46-14	6112-6114	of	_
46-15	6115-6118	the	_
46-16	6119-6129	procedures	_
46-17	6130-6139	described	_
46-18	6140-6142	in	_
46-19	6143-6144	.	_

47-1	6145-6151	During	_
47-2	6152-6156	this	_
47-3	6157-6161	task	_
47-4	6162-6163	,	_
47-5	6164-6176	participants	_
47-6	6177-6183	viewed	_
47-7	6184-6185	a	_
47-8	6186-6192	target	_
47-9	6193-6200	picture	_
47-10	6201-6204	and	_
47-11	6205-6208	two	_
47-12	6209-6219	additional	_
47-13	6220-6228	pictures	_
47-14	6229-6230	;	_
47-15	6231-6243	participants	_
47-16	6244-6248	were	_
47-17	6249-6259	instructed	_
47-18	6260-6262	to	_
47-19	6263-6269	select	_
47-20	6270-6273	the	_
47-21	6274-6281	picture	_
47-22	6282-6286	that	_
47-23	6287-6294	matched	_
47-24	6295-6298	the	_
47-25	6299-6305	target	_
47-26	6306-6308	by	_
47-27	6309-6317	pressing	_
47-28	6318-6321	the	_
47-29	6322-6335	corresponding	_
47-30	6336-6342	button	_
47-31	6343-6344	.	_

48-1	6345-6348	Six	_
48-2	6349-6354	types	_
48-3	6355-6357	of	_
48-4	6358-6366	pictures	_
48-5	6367-6371	were	_
48-6	6372-6377	shown	_
48-7	6378-6379	:	_
48-8	6380-6381	1	_
48-9	6382-6383	)	_
48-10	6384-6389	angry	_
48-11	6390-6395	faces	_
48-12	6396-6397	,	_
48-13	6398-6399	2	_
48-14	6400-6401	)	_
48-15	6402-6405	sad	_
48-16	6406-6411	faces	_
48-17	6412-6413	,	_
48-18	6414-6415	3	_
48-19	6416-6417	)	_
48-20	6418-6425	fearful	_
48-21	6426-6431	faces	_
48-22	6432-6433	,	_
48-23	6434-6435	4	_
48-24	6436-6437	)	_
48-25	6438-6443	happy	_
48-26	6444-6449	faces	_
48-27	6450-6451	,	_
48-28	6452-6453	5	_
48-29	6454-6455	)	_
48-30	6456-6463	neutral	_
48-31	6464-6469	faces	_
48-32	6470-6471	,	_
48-33	6472-6475	and	_
48-34	6476-6477	6	_
48-35	6478-6479	)	_
48-36	6480-6486	shapes	_
48-37	6487-6488	.	_

49-1	6489-6494	There	_
49-2	6495-6499	were	_
49-3	6500-6503	two	_
49-4	6504-6515	interleaved	_
49-5	6516-6522	blocks	_
49-6	6523-6525	of	_
49-7	6526-6530	each	_
49-8	6531-6538	picture	_
49-9	6539-6543	type	_
49-10	6544-6545	.	_

50-1	6546-6551	Prior	_
50-2	6552-6554	to	_
50-3	6555-6559	each	_
50-4	6560-6565	block	_
50-5	6566-6567	,	_
50-6	6568-6580	instructions	_
50-7	6581-6585	were	_
50-8	6586-6595	presented	_
50-9	6596-6599	for	_
50-10	6600-6603	two	_
50-11	6604-6611	seconds	_
50-12	6612-6615	for	_
50-13	6616-6624	subjects	_
50-14	6625-6627	to	_
50-15	6628-6629	“	_
50-16	6630-6635	match	_
50-17	6636-6642	shapes	_
50-18	6643-6644	”	_
50-19	6645-6647	or	_
50-20	6648-6649	“	_
50-21	6650-6655	match	_
50-22	6656-6661	faces	_
50-23	6662-6663	”	_
50-24	6664-6665	.	_

51-1	6666-6670	Each	_
51-2	6671-6676	block	_
51-3	6677-6686	contained	_
51-4	6687-6688	6	_
51-5	6689-6695	images	_
51-6	6696-6698	of	_
51-7	6699-6702	the	_
51-8	6703-6707	same	_
51-9	6708-6712	type	_
51-10	6713-6714	,	_
51-11	6715-6724	displayed	_
51-12	6725-6728	for	_
51-13	6729-6730	5	_
51-14	6731-6732	s	_
51-15	6733-6737	with	_
51-16	6738-6740	no	_
51-17	6741-6755	inter-stimulus	_
51-18	6756-6764	interval	_
51-19	6765-6766	,	_
51-20	6767-6770	for	_
51-21	6771-6772	a	_
51-22	6773-6778	total	_
51-23	6779-6781	of	_
51-24	6782-6784	30	_
51-25	6785-6786	s	_
51-26	6787-6790	per	_
51-27	6791-6796	block	_
51-28	6797-6798	.	_

52-1	6799-6803	Male	_
52-2	6804-6807	and	_
52-3	6808-6814	female	_
52-4	6815-6820	faces	_
52-5	6821-6825	were	_
52-6	6826-6833	equally	_
52-7	6834-6845	represented	_
52-8	6846-6847	.	_

53-1	6848-6851	For	_
53-2	6852-6855	the	_
53-3	6856-6863	purpose	_
53-4	6864-6866	of	_
53-5	6867-6871	this	_
53-6	6872-6877	study	_
53-7	6878-6879	,	_
53-8	6880-6882	we	_
53-9	6883-6890	focused	_
53-10	6891-6893	on	_
53-11	6894-6902	negative	_
53-12	6903-6912	emotional	_
53-13	6913-6918	faces	_
53-14	6919-6926	because	_
53-15	6927-6930	the	_
53-16	6931-6939	previous	_
53-17	6940-6950	literature	_
53-18	6951-6954	has	_
53-19	6955-6967	consistently	_
53-20	6968-6973	found	_
53-21	6974-6989	alcohol-related	_
53-22	6990-6997	effects	_
53-23	6998-7000	in	_
53-24	7001-7005	this	_
53-25	7006-7012	domain	_
53-26	7013-7016	and	_
53-27	7017-7019	in	_
53-28	7020-7024	fact	_
53-29	7025-7029	have	_
53-30	7030-7034	used	_
53-31	7035-7040	happy	_
53-32	7041-7046	faces	_
53-33	7047-7049	as	_
53-34	7050-7051	a	_
53-35	7052-7059	control	_
53-36	7060-7069	condition	_
53-37	7070-7072	in	_
53-38	7073-7077	some	_
53-39	7078-7083	cases	_
53-40	7084-7085	.	_

54-1	7086-7090	This	_
54-2	7091-7095	task	_
54-3	7096-7098	is	_
54-4	7099-7101	an	_
54-5	7102-7110	implicit	_
54-6	7111-7121	processing	_
54-7	7122-7126	task	_
54-8	7127-7128	;	_
54-9	7129-7139	behavioral	_
54-10	7140-7149	responses	_
54-11	7150-7154	were	_
54-12	7155-7158	not	_
54-13	7159-7161	of	_
54-14	7162-7170	interest	_
54-15	7171-7174	and	_
54-16	7175-7179	thus	_
54-17	7180-7183	not	_
54-18	7184-7192	included	_
54-19	7193-7195	in	_
54-20	7196-7199	the	_
54-21	7200-7205	model	_
54-22	7206-7207	.	_

55-1	7208-7215	Imaging	_
55-2	7216-7220	data	_
55-3	7221-7232	acquisition	_
55-4	7233-7245	Participants	_
55-5	7246-7250	were	_
55-6	7251-7258	scanned	_
55-7	7259-7261	on	_
55-8	7262-7263	a	_
55-9	7264-7271	Siemens	_
55-10	7272-7274	3T	http://maven.renci.org/NeuroBridge/neurobridge#Thing
55-11	7275-7280	Skyra	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-12	7281-7289	Magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-13	7290-7299	Resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-14	7300-7307	Imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-15	7308-7309	(	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-16	7310-7313	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-17	7314-7315	)	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-18	7316-7323	machine	_
55-19	7324-7326	at	_
55-20	7327-7330	the	_
55-21	7331-7334	NIH	_
55-22	7335-7343	Clinical	_
55-23	7344-7350	Center	_
55-24	7351-7352	.	_

56-1	7353-7358	While	_
56-2	7359-7361	in	_
56-3	7362-7365	the	_
56-4	7366-7373	scanner	_
56-5	7374-7375	,	_
56-6	7376-7380	they	_
56-7	7381-7390	completed	_
56-8	7391-7392	a	_
56-9	7393-7397	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
56-10	7398-7402	scan	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
56-11	7403-7404	,	_
56-12	7405-7406	a	_
56-13	7407-7414	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
56-14	7415-7419	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
56-15	7420-7421	,	_
56-16	7422-7425	and	_
56-17	7426-7430	then	_
56-18	7431-7434	two	_
56-19	7435-7440	task-	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
56-20	7441-7445	fMRI	_
56-21	7446-7451	scans	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
56-22	7452-7453	,	_
56-23	7454-7463	described	_
56-24	7464-7469	above	_
56-25	7470-7471	.	_

57-1	7472-7475	For	_
57-2	7476-7479	the	_
57-3	7480-7487	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
57-4	7488-7489	,	_
57-5	7490-7502	participants	_
57-6	7503-7506	lay	_
57-7	7507-7509	in	_
57-8	7510-7513	the	_
57-9	7514-7518	dark	_
57-10	7519-7522	for	_
57-11	7523-7526	ten	_
57-12	7527-7534	minutes	_
57-13	7535-7539	with	_
57-14	7540-7544	eyes	_
57-15	7545-7549	open	_
57-16	7550-7553	and	_
57-17	7554-7556	no	_
57-18	7557-7567	additional	_
57-19	7568-7575	stimuli	_
57-20	7576-7577	.	_

58-1	7578-7581	All	_
58-2	7582-7587	three	_
58-3	7588-7598	functional	_
58-4	7599-7604	scans	_
58-5	7605-7609	were	_
58-6	7610-7618	acquired	_
58-7	7619-7624	using	_
58-8	7625-7627	an	_
58-9	7628-7646	echoplanar-imaging	_
58-10	7647-7652	pulse	_
58-11	7653-7661	sequence	_
58-12	7662-7663	(	_
58-13	7664-7666	TR	_
58-14	7667-7668	:	_
58-15	7669-7673	2000	_
58-16	7674-7678	msec	_
58-17	7679-7680	,	_
58-18	7681-7683	TE	_
58-19	7684-7685	:	_
58-20	7686-7688	30	_
58-21	7689-7693	msec	_
58-22	7694-7695	,	_
58-23	7696-7700	flip	_
58-24	7701-7706	angle	_
58-25	7707-7708	:	_
58-26	7709-7712	90°	_
58-27	7713-7714	,	_
58-28	7715-7718	FOV	_
58-29	7719-7720	:	_
58-30	7721-7723	24	_
58-31	7724-7725	×	_
58-32	7726-7728	24	_
58-33	7729-7731	cm	_
58-34	7732-7733	,	_
58-35	7734-7736	38	_
58-36	7737-7739	mm	_
58-37	7740-7745	slice	_
58-38	7746-7755	thickness	_
58-39	7756-7757	,	_
58-40	7758-7760	36	_
58-41	7761-7767	slices	_
58-42	7768-7769	,	_
58-43	7770-7781	multi-slice	_
58-44	7782-7786	mode	_
58-45	7787-7788	:	_
58-46	7789-7800	interleaved	_
58-47	7801-7802	)	_
58-48	7803-7804	.	_

59-1	7805-7810	Tasks	_
59-2	7811-7815	were	_
59-3	7816-7825	presented	_
59-4	7826-7832	during	_
59-5	7833-7837	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
59-6	7838-7843	using	_
59-7	7844-7857	Presentation®	_
59-8	7858-7866	software	_
59-9	7867-7868	(	_
59-10	7869-7876	Version	_
59-11	7877-7881	18.0	_
59-12	7882-7883	,	_
59-13	7884-7885	,	_
59-14	7886-7894	Berkeley	_
59-15	7895-7896	,	_
59-16	7897-7899	CA	_
59-17	7900-7901	,	_
59-18	7902-7919	www.neurojobs.com	_
59-19	7920-7921	)	_
59-20	7922-7924	in	_
59-21	7925-7926	a	_
59-22	7927-7942	counterbalanced	_
59-23	7943-7948	order	_
59-24	7949-7950	.	_

60-1	7951-7954	The	_
60-2	7955-7959	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
60-3	7960-7964	scan	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
60-4	7965-7968	was	_
60-5	7969-7977	acquired	_
60-6	7978-7983	using	_
60-7	7984-7985	a	_
60-8	7986-7995	T1-MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
60-9	7996-8004	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
60-10	8005-8006	(	_
60-11	8007-8009	TR	_
60-12	8010-8011	:	_
60-13	8012-8016	1900	_
60-14	8017-8021	msec	_
60-15	8022-8023	,	_
60-16	8024-8026	TE	_
60-17	8027-8028	:	_
60-18	8029-8033	3.09	_
60-19	8034-8038	msec	_
60-20	8039-8040	,	_
60-21	8041-8045	flip	_
60-22	8046-8051	angle	_
60-23	8052-8053	:	_
60-24	8054-8057	10°	_
60-25	8058-8059	,	_
60-26	8060-8063	FOV	_
60-27	8064-8065	:	_
60-28	8066-8068	24	_
60-29	8069-8070	×	_
60-30	8071-8073	24	_
60-31	8074-8076	cm	_
60-32	8077-8078	,	_
60-33	8079-8080	1	_
60-34	8081-8083	mm	_
60-35	8084-8089	slice	_
60-36	8090-8099	thickness	_
60-37	8100-8101	,	_
60-38	8102-8105	144	_
60-39	8106-8112	slices	_
60-40	8113-8114	,	_
60-41	8115-8125	muli-slice	_
60-42	8126-8130	mode	_
60-43	8131-8132	:	_
60-44	8133-8139	single	_
60-45	8140-8144	shot	_
60-46	8145-8146	)	_
60-47	8147-8148	.	_

61-1	8149-8154	Image	_
61-2	8155-8165	processing	_
61-3	8166-8169	and	_
61-4	8170-8174	data	_
61-5	8175-8183	analysis	_
61-6	8184-8187	See	_
61-7	8188-8191	Fig	_
61-8	8192-8193	.	_

62-1	8194-8195	1	_
62-2	8196-8199	for	_
62-3	8200-8201	a	_
62-4	8202-8211	flowchart	_
62-5	8212-8214	of	_
62-6	8215-8223	analysis	_
62-7	8224-8234	procedures	_
62-8	8235-8236	.	_

63-1	8237-8240	The	_
63-2	8241-8245	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
63-3	8246-8250	data	_
63-4	8251-8255	from	_
63-5	8256-8260	each	_
63-6	8261-8268	subject	_
63-7	8269-8273	were	_
63-8	8274-8283	processed	_
63-9	8284-8289	using	_
63-10	8290-8294	AFNI	_
63-11	8295-8296	(	_
63-12	8297-8305	v16.2.16	_
63-13	8306-8307	:	_
63-14	8308-8325	afni.nimh.nih.gov	_
63-15	8326-8327	)	_
63-16	8328-8329	.	_

64-1	8330-8343	Preprocessing	_
64-2	8344-8347	was	_
64-3	8348-8352	done	_
64-4	8353-8355	on	_
64-5	8356-8357	a	_
64-6	8358-8372	single-subject	_
64-7	8373-8378	basis	_
64-8	8379-8380	.	_

65-1	8381-8384	The	_
65-2	8385-8390	first	_
65-3	8391-8396	three	_
65-4	8397-8400	TRs	_
65-5	8401-8405	were	_
65-6	8406-8413	removed	_
65-7	8414-8418	from	_
65-8	8419-8423	each	_
65-9	8424-8428	time	_
65-10	8429-8435	course	_
65-11	8436-8437	.	_

66-1	8438-8442	Then	_
66-2	8443-8444	,	_
66-3	8445-8454	3dDespike	_
66-4	8455-8458	was	_
66-5	8459-8466	applied	_
66-6	8467-8469	to	_
66-7	8470-8476	smooth	_
66-8	8477-8483	spikes	_
66-9	8484-8486	in	_
66-10	8487-8493	signal	_
66-11	8494-8498	over	_
66-12	8499-8502	the	_
66-13	8503-8507	time	_
66-14	8508-8514	course	_
66-15	8515-8516	.	_

67-1	8517-8521	Next	_
67-2	8522-8523	,	_
67-3	8524-8528	time	_
67-4	8529-8536	courses	_
67-5	8537-8541	were	_
67-6	8542-8549	shifted	_
67-7	8550-8553	for	_
67-8	8554-8558	each	_
67-9	8559-8564	voxel	_
67-10	8565-8567	to	_
67-11	8568-8570	be	_
67-12	8571-8578	aligned	_
67-13	8579-8581	to	_
67-14	8582-8585	the	_
67-15	8586-8590	same	_
67-16	8591-8599	temporal	_
67-17	8600-8606	origin	_
67-18	8607-8609	by	_
67-19	8610-8620	detrending	_
67-20	8621-8625	then	_
67-21	8626-8639	interpolating	_
67-22	8640-8643	the	_
67-23	8644-8648	time	_
67-24	8649-8655	series	_
67-25	8656-8657	.	_

68-1	8658-8665	Volumes	_
68-2	8666-8672	across	_
68-3	8673-8676	the	_
68-4	8677-8681	time	_
68-5	8682-8688	series	_
68-6	8689-8693	were	_
68-7	8694-8698	then	_
68-8	8699-8706	aligned	_
68-9	8707-8709	to	_
68-10	8710-8713	the	_
68-11	8714-8718	base	_
68-12	8719-8725	volume	_
68-13	8726-8729	and	_
68-14	8730-8732	to	_
68-15	8733-8736	the	_
68-16	8737-8751	skull-stripped	_
68-17	8752-8759	anatomy	_
68-18	8760-8762	of	_
68-19	8763-8766	the	_
68-20	8767-8774	subject	_
68-21	8775-8776	,	_
68-22	8777-8781	then	_
68-23	8782-8788	warped	_
68-24	8789-8791	to	_
68-25	8792-8800	standard	_
68-26	8801-8810	Talairach	_
68-27	8811-8816	space	_
68-28	8817-8822	using	_
68-29	8823-8826	the	_
68-30	8827-8837	non-linear	_
68-31	8838-8845	warping	_
68-32	8846-8855	procedure	_
68-33	8856-8868	3dNwarpApply	_
68-34	8869-8870	.	_

69-1	8871-8878	Finally	_
69-2	8879-8880	,	_
69-3	8881-8885	each	_
69-4	8886-8892	volume	_
69-5	8893-8896	was	_
69-6	8897-8904	blurred	_
69-7	8905-8909	with	_
69-8	8910-8911	a	_
69-9	8912-8916	4-mm	_
69-10	8917-8927	full-width	_
69-11	8928-8930	at	_
69-12	8931-8943	half-maximum	_
69-13	8944-8952	Gaussian	_
69-14	8953-8962	smoothing	_
69-15	8963-8969	kernel	_
69-16	8970-8971	.	_

70-1	8972-8975	For	_
70-2	8976-8979	the	_
70-3	8980-8989	task-fMRI	_
70-4	8990-8994	data	_
70-5	8995-8996	,	_
70-6	8997-9000	TRs	_
70-7	9001-9006	where	_
70-8	9007-9010	the	_
70-9	9011-9017	motion	_
70-10	9018-9028	derivative	_
70-11	9029-9034	value	_
70-12	9035-9038	was	_
70-13	9039-9042	0.3	_
70-14	9043-9048	mm/TR	_
70-15	9049-9051	or	_
70-16	9052-9058	higher	_
70-17	9059-9063	were	_
70-18	9064-9072	censored	_
70-19	9073-9077	from	_
70-20	9078-9084	future	_
70-21	9085-9093	analysis	_
70-22	9094-9097	and	_
70-23	9098-9105	stimuli	_
70-24	9106-9111	onset	_
70-25	9112-9117	times	_
70-26	9118-9122	were	_
70-27	9123-9132	regressed	_
70-28	9133-9135	to	_
70-29	9136-9144	identify	_
70-30	9145-9151	signal	_
70-31	9152-9162	associated	_
70-32	9163-9167	with	_
70-33	9168-9172	each	_
70-34	9173-9182	condition	_
70-35	9183-9184	,	_
70-36	9185-9189	with	_
70-37	9190-9198	demeaned	_
70-38	9199-9205	motion	_
70-39	9206-9216	parameters	_
70-40	9217-9220	and	_
70-41	9221-9226	their	_
70-42	9227-9238	derivatives	_
70-43	9239-9248	regressed	_
70-44	9249-9251	to	_
70-45	9252-9258	remove	_
70-46	9259-9267	variance	_
70-47	9268-9278	associated	_
70-48	9279-9283	with	_
70-49	9284-9292	movement	_
70-50	9293-9294	.	_

71-1	9295-9297	In	_
71-2	9298-9302	rest	_
71-3	9303-9307	data	_
71-4	9308-9309	,	_
71-5	9310-9320	individual	_
71-6	9321-9325	data	_
71-7	9326-9330	with	_
71-8	9331-9333	an	_
71-9	9334-9341	average	_
71-10	9342-9348	motion	_
71-11	9349-9359	derivative	_
71-12	9360-9365	value	_
71-13	9366-9368	of	_
71-14	9369-9372	0.3	_
71-15	9373-9378	mm/TR	_
71-16	9379-9381	or	_
71-17	9382-9388	higher	_
71-18	9389-9390	(	_
71-19	9391-9392	n	_
71-20	9393-9394	=	_
71-21	9395-9396	5	_
71-22	9397-9398	)	_
71-23	9399-9400	,	_
71-24	9401-9405	with	_
71-25	9406-9407	>	_
71-26	9408-9409	3	_
71-27	9410-9411	%	_
71-28	9412-9414	of	_
71-29	9415-9418	TRs	_
71-30	9419-9424	being	_
71-31	9425-9435	identified	_
71-32	9436-9438	as	_
71-33	9439-9444	above	_
71-34	9445-9449	that	_
71-35	9450-9453	cut	_
71-36	9454-9457	off	_
71-37	9458-9459	(	_
71-38	9460-9461	n	_
71-39	9462-9463	=	_
71-40	9464-9465	2	_
71-41	9466-9467	)	_
71-42	9468-9469	,	_
71-43	9470-9472	or	_
71-44	9473-9477	with	_
71-45	9478-9479	>	_
71-46	9480-9482	50	_
71-47	9483-9486	TRs	_
71-48	9487-9493	having	_
71-49	9494-9500	motion	_
71-50	9501-9505	were	_
71-51	9506-9513	removed	_
71-52	9514-9519	prior	_
71-53	9520-9522	to	_
71-54	9523-9528	group	_
71-55	9529-9534	level	_
71-56	9535-9543	analysis	_
71-57	9544-9545	.	_

72-1	9546-9556	Additional	_
72-2	9557-9564	control	_
72-3	9565-9568	for	_
72-4	9569-9577	nuisance	_
72-5	9578-9587	variables	_
72-6	9588-9596	occurred	_
72-7	9597-9599	as	_
72-8	9600-9604	part	_
72-9	9605-9607	of	_
72-10	9608-9611	the	_
72-11	9612-9623	independent	_
72-12	9624-9634	components	_
72-13	9635-9643	analysis	_
72-14	9644-9645	(	_
72-15	9646-9649	ICA	_
72-16	9650-9651	)	_
72-17	9652-9661	procedure	_
72-18	9662-9663	,	_
72-19	9664-9673	described	_
72-20	9674-9679	below	_
72-21	9680-9681	,	_
72-22	9682-9687	which	_
72-23	9688-9698	identified	_
72-24	9699-9702	and	_
72-25	9703-9712	extracted	_
72-26	9713-9719	signal	_
72-27	9720-9723	due	_
72-28	9724-9726	to	_
72-29	9727-9734	sources	_
72-30	9735-9739	such	_
72-31	9740-9742	as	_
72-32	9743-9749	motion	_
72-33	9750-9752	or	_
72-34	9753-9764	physiologic	_
72-35	9765-9770	noise	_
72-36	9771-9772	.	_

73-1	9773-9783	Individual	_
73-2	9784-9789	masks	_
73-3	9790-9793	and	_
73-4	9794-9807	registrations	_
73-5	9808-9814	across	_
73-6	9815-9823	modality	_
73-7	9824-9828	were	_
73-8	9829-9837	visually	_
73-9	9838-9847	inspected	_
73-10	9848-9850	to	_
73-11	9851-9857	ensure	_
73-12	9858-9865	quality	_
73-13	9866-9869	and	_
73-14	9870-9877	several	_
73-15	9878-9888	additional	_
73-16	9889-9897	subjects	_
73-17	9898-9902	were	_
73-18	9903-9910	removed	_
73-19	9911-9915	from	_
73-20	9916-9919	the	_
73-21	9920-9928	analysis	_
73-22	9929-9930	(	_
73-23	9931-9934	MID	_
73-24	9935-9936	:	_
73-25	9937-9938	n	_
73-26	9939-9940	=	_
73-27	9941-9942	2	_
73-28	9943-9944	,	_
73-29	9945-9949	Face	_
73-30	9950-9951	:	_
73-31	9952-9953	n	_
73-32	9954-9955	=	_
73-33	9956-9957	3	_
73-34	9958-9959	;	_
73-35	9960-9965	final	_
73-36	9966-9974	subjects	_
73-37	9975-9976	:	_
73-38	9977-9984	rs-fMRI	_
73-39	9985-9986	,	_
73-40	9987-9988	n	_
73-41	9989-9990	=	_
73-42	9991-9993	52	_
73-43	9994-9995	,	_
73-44	9996-10000	sMRI	_
73-45	10001-10002	,	_
73-46	10003-10004	n	_
73-47	10005-10006	=	_
73-48	10007-10009	59	_
73-49	10010-10011	,	_
73-50	10012-10015	MID	_
73-51	10016-10017	n	_
73-52	10018-10019	=	_
73-53	10020-10022	57	_
73-54	10023-10024	,	_
73-55	10025-10029	Face	_
73-56	10030-10038	Matching	_
73-57	10039-10040	n	_
73-58	10041-10042	=	_
73-59	10043-10045	56	_
73-60	10046-10047	)	_
73-61	10048-10049	.	_

74-1	10050-10053	The	_
74-2	10054-10061	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
74-3	10062-10066	data	_
74-4	10067-10071	were	_
74-5	10072-10080	analyzed	_
74-6	10081-10086	using	_
74-7	10087-10090	ICA	_
74-8	10091-10093	in	_
74-9	10094-10097	the	_
74-10	10098-10102	GIFT	_
74-11	10103-10104	(	_
74-12	10105-10110	v3.0b	_
74-13	10111-10112	)	_
74-14	10113-10120	toolbox	_
74-15	10121-10123	in	_
74-16	10124-10127	SPM	_
74-17	10128-10130	12	_
74-18	10131-10136	after	_
74-19	10137-10140	the	_
74-20	10141-10154	preprocessing	_
74-21	10155-10164	described	_
74-22	10165-10170	above	_
74-23	10171-10172	(	_
74-24	10173-10174	:	_
74-25	10175-10204	mialab.mrn.org/software/gift/	_
74-26	10205-10206	)	_
74-27	10207-10208	.	_

75-1	10209-10212	ICA	_
75-2	10213-10215	is	_
75-3	10216-10217	a	_
75-4	10218-10229	data-driven	_
75-5	10230-10239	technique	_
75-6	10240-10244	that	_
75-7	10245-10253	extracts	_
75-8	10254-10263	maximally	_
75-9	10264-10273	different	_
75-10	10274-10285	independent	_
75-11	10286-10293	sources	_
75-12	10294-10298	from	_
75-13	10299-10305	signal	_
75-14	10306-10310	data	_
75-15	10311-10312	.	_

76-1	10313-10315	It	_
76-2	10316-10328	concatenates	_
76-3	10329-10333	data	_
76-4	10334-10340	across	_
76-5	10341-10344	the	_
76-6	10345-10349	time	_
76-7	10350-10356	series	_
76-8	10357-10358	,	_
76-9	10359-10369	extracting	_
76-10	10370-10378	networks	_
76-11	10379-10381	of	_
76-12	10382-10389	related	_
76-13	10390-10401	fluctuating	_
76-14	10402-10410	activity	_
76-15	10411-10412	.	_

77-1	10413-10415	In	_
77-2	10416-10419	the	_
77-3	10420-10427	primary	_
77-4	10428-10434	sample	_
77-5	10435-10436	,	_
77-6	10437-10442	group	_
77-7	10443-10446	ICA	_
77-8	10447-10450	was	_
77-9	10451-10455	used	_
77-10	10456-10458	to	_
77-11	10459-10466	extract	_
77-12	10467-10469	75	_
77-13	10470-10479	component	_
77-14	10480-10484	time	_
77-15	10485-10491	series	_
77-16	10492-10497	using	_
77-17	10498-10499	a	_
77-18	10500-10503	PCA	_
77-19	10504-10509	based	_
77-20	10510-10520	separation	_
77-21	10521-10530	algorithm	_
77-22	10531-10533	at	_
77-23	10534-10535	a	_
77-24	10536-10550	single-subject	_
77-25	10551-10556	level	_
77-26	10557-10558	.	_

78-1	10559-10563	Then	_
78-2	10564-10565	a	_
78-3	10566-10571	group	_
78-4	10572-10575	PCA	_
78-5	10576-10580	step	_
78-6	10581-10584	was	_
78-7	10585-10588	run	_
78-8	10589-10591	to	_
78-9	10592-10598	reduce	_
78-10	10599-10602	the	_
78-11	10603-10607	data	_
78-12	10608-10610	to	_
78-13	10611-10612	a	_
78-14	10613-10619	single	_
78-15	10620-10623	set	_
78-16	10624-10626	of	_
78-17	10627-10637	components	_
78-18	10638-10641	for	_
78-19	10642-10645	the	_
78-20	10646-10651	group	_
78-21	10652-10653	.	_

79-1	10654-10668	Single-subject	_
79-2	10669-10673	time	_
79-3	10674-10681	courses	_
79-4	10682-10685	for	_
79-5	10686-10690	each	_
79-6	10691-10696	group	_
79-7	10697-10699	IC	_
79-8	10700-10704	were	_
79-9	10705-10723	back-reconstructed	_
79-10	10724-10729	using	_
79-11	10730-10733	the	_
79-12	10734-10739	GICA3	_
79-13	10740-10749	algorithm	_
79-14	10750-10751	.	_

80-1	10752-10755	ICs	_
80-2	10756-10760	were	_
80-3	10761-10769	reviewed	_
80-4	10770-10778	manually	_
80-5	10779-10780	,	_
80-6	10781-10784	and	_
80-7	10785-10787	31	_
80-8	10788-10798	components	_
80-9	10799-10803	were	_
80-10	10804-10814	identified	_
80-11	10815-10817	as	_
80-12	10818-10823	noise	_
80-13	10824-10831	related	_
80-14	10832-10835	and	_
80-15	10836-10843	removed	_
80-16	10844-10845	.	_

81-1	10846-10855	Resulting	_
81-2	10856-10867	independent	_
81-3	10868-10878	components	_
81-4	10879-10880	(	_
81-5	10881-10884	ICs	_
81-6	10885-10886	)	_
81-7	10887-10891	were	_
81-8	10892-10899	labeled	_
81-9	10900-10905	using	_
81-10	10906-10909	the	_
81-11	10910-10919	Component	_
81-12	10920-10928	Labeling	_
81-13	10929-10936	toolbox	_
81-14	10937-10943	within	_
81-15	10944-10948	GIFT	_
81-16	10949-10950	,	_
81-17	10951-10956	where	_
81-18	10957-10960	the	_
81-19	10961-10966	label	_
81-20	10967-10970	was	_
81-21	10971-10980	generated	_
81-22	10981-10986	based	_
81-23	10987-10989	on	_
81-24	10990-11001	correlation	_
81-25	11002-11006	with	_
81-26	11007-11014	Resting	_
81-27	11015-11020	State	_
81-28	11021-11028	Network	_
81-29	11029-11033	mask	_
81-30	11034-11035	.	_

82-1	11036-11041	Based	_
82-2	11042-11044	on	_
82-3	11045-11048	our	_
82-4	11049-11050	a	_
82-5	11051-11057	priori	_
82-6	11058-11068	hypotheses	_
82-7	11069-11070	,	_
82-8	11071-11074	ICs	_
82-9	11075-11082	labeled	_
82-10	11083-11091	anterior	_
82-11	11092-11100	salience	_
82-12	11101-11108	network	_
82-13	11109-11110	(	_
82-14	11111-11114	ASN	_
82-15	11115-11116	)	_
82-16	11117-11118	,	_
82-17	11119-11128	posterior	_
82-18	11129-11137	salience	_
82-19	11138-11145	network	_
82-20	11146-11147	(	_
82-21	11148-11151	PSN	_
82-22	11152-11153	)	_
82-23	11154-11155	,	_
82-24	11156-11162	dorsal	_
82-25	11163-11170	Default	_
82-26	11171-11175	Mode	_
82-27	11176-11183	Network	_
82-28	11184-11185	(	_
82-29	11186-11190	dDMN	_
82-30	11191-11192	)	_
82-31	11193-11194	,	_
82-32	11195-11202	ventral	_
82-33	11203-11210	Default	_
82-34	11211-11215	Mode	_
82-35	11216-11223	Network	_
82-36	11224-11225	(	_
82-37	11226-11230	vDMN	_
82-38	11231-11232	)	_
82-39	11233-11234	,	_
82-40	11235-11239	left	_
82-41	11240-11242	or	_
82-42	11243-11248	right	_
82-43	11249-11258	Executive	_
82-44	11259-11266	Control	_
82-45	11267-11274	Network	_
82-46	11275-11276	(	_
82-47	11277-11280	ECN	_
82-48	11281-11282	)	_
82-49	11283-11284	,	_
82-50	11285-11287	or	_
82-51	11288-11293	basal	_
82-52	11294-11301	ganglia	_
82-53	11302-11303	(	_
82-54	11304-11306	BG	_
82-55	11307-11308	)	_
82-56	11309-11313	were	_
82-57	11314-11324	identified	_
82-58	11325-11326	.	_

83-1	11327-11336	Following	_
83-2	11337-11340	all	_
83-3	11341-11345	data	_
83-4	11346-11355	selection	_
83-5	11356-11366	procedures	_
83-6	11367-11368	,	_
83-7	11369-11376	rs-fMRI	_
83-8	11377-11381	data	_
83-9	11382-11386	from	_
83-10	11387-11390	the	_
83-11	11391-11401	validation	_
83-12	11402-11408	sample	_
83-13	11409-11412	was	_
83-14	11413-11422	processed	_
83-15	11423-11425	by	_
83-16	11426-11445	back-reconstructing	_
83-17	11446-11453	subject	_
83-18	11454-11458	data	_
83-19	11459-11463	into	_
83-20	11464-11467	the	_
83-21	11468-11475	already	_
83-22	11476-11483	defined	_
83-23	11484-11493	component	_
83-24	11494-11499	space	_
83-25	11500-11505	using	_
83-26	11506-11509	the	_
83-27	11510-11517	GIG-ICA	_
83-28	11518-11527	algorithm	_
83-29	11528-11529	.	_

84-1	11530-11537	Between	_
84-2	11538-11547	component	_
84-3	11548-11558	functional	_
84-4	11559-11566	network	_
84-5	11567-11579	connectivity	_
84-6	11580-11581	(	_
84-7	11582-11585	FNC	_
84-8	11586-11587	)	_
84-9	11588-11591	was	_
84-10	11592-11596	also	_
84-11	11597-11605	examined	_
84-12	11606-11607	.	_

85-1	11608-11612	This	_
85-2	11613-11622	procedure	_
85-3	11623-11633	correlated	_
85-4	11634-11637	the	_
85-5	11638-11642	time	_
85-6	11643-11650	courses	_
85-7	11651-11653	of	_
85-8	11654-11658	each	_
85-9	11659-11661	IC	_
85-10	11662-11666	with	_
85-11	11667-11671	each	_
85-12	11672-11677	other	_
85-13	11678-11679	,	_
85-14	11680-11688	creating	_
85-15	11689-11690	a	_
85-16	11691-11697	matrix	_
85-17	11698-11700	of	_
85-18	11701-11710	component	_
85-19	11711-11723	connectivity	_
85-20	11724-11725	.	_

86-1	11726-11730	This	_
86-2	11731-11737	matrix	_
86-3	11738-11741	was	_
86-4	11742-11752	calculated	_
86-5	11753-11765	individually	_
86-6	11766-11769	for	_
86-7	11770-11774	each	_
86-8	11775-11782	subject	_
86-9	11783-11784	,	_
86-10	11785-11790	based	_
86-11	11791-11793	on	_
86-12	11794-11812	back-reconstructed	_
86-13	11813-11822	component	_
86-14	11823-11827	data	_
86-15	11828-11829	.	_

87-1	11830-11833	See	_
87-2	11834-11846	Supplemental	_
87-3	11847-11855	Material	_
87-4	11856-11857	1	_
87-5	11858-11861	for	_
87-6	11862-11870	unimodal	_
87-7	11871-11879	analysis	_
87-8	11880-11887	methods	_
87-9	11888-11891	and	_
87-10	11892-11899	results	_
87-11	11900-11901	.	_

88-1	11902-11906	sMRI	_
88-2	11907-11911	data	_
88-3	11912-11916	were	_
88-4	11917-11925	analyzed	_
88-5	11926-11931	using	_
88-6	11932-11942	Freesurfer	_
88-7	11943-11944	(	_
88-8	11945-11952	version	_
88-9	11953-11958	5.3.0	_
88-10	11959-11960	:	_
88-11	11961-11987	surfer.nmr.mgh.harvard.edu	_
88-12	11988-11989	)	_
88-13	11990-11991	.	_

89-1	11992-11994	We	_
89-2	11995-11999	used	_
89-3	12000-12002	an	_
89-4	12003-12020	auto-segmentation	_
89-5	12021-12030	procedure	_
89-6	12031-12033	on	_
89-7	12034-12044	individual	_
89-8	12045-12053	subjects	_
89-9	12054-12059	based	_
89-10	12060-12062	on	_
89-11	12063-12066	the	_
89-12	12067-12075	standard	_
89-13	12076-12086	Freesurfer	_
89-14	12087-12090	and	_
89-15	12091-12100	Destrieux	_
89-16	12101-12108	atlases	_
89-17	12109-12111	to	_
89-18	12112-12119	measure	_
89-19	12120-12124	gray	_
89-20	12125-12131	matter	_
89-21	12132-12138	volume	_
89-22	12139-12141	of	_
89-23	12142-12152	structures	_
89-24	12153-12154	.	_

90-1	12155-12158	The	_
90-2	12159-12168	T1-MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
90-3	12169-12173	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
90-4	12174-12178	scan	_
90-5	12179-12182	was	_
90-6	12183-12188	first	_
90-7	12189-12198	conformed	_
90-8	12199-12201	to	_
90-9	12202-12203	1	_
90-10	12204-12206	mm	_
90-11	12207-12212	voxel	_
90-12	12213-12217	size	_
90-13	12218-12219	,	_
90-14	12220-12228	resliced	_
90-15	12229-12234	using	_
90-16	12235-12244	trilinear	_
90-17	12245-12258	interpolation	_
90-18	12259-12260	,	_
90-19	12261-12272	transformed	_
90-20	12273-12275	to	_
90-21	12276-12285	Talairach	_
90-22	12286-12291	space	_
90-23	12292-12293	,	_
90-24	12294-12303	corrected	_
90-25	12304-12307	for	_
90-26	12308-12317	intensity	_
90-27	12318-12332	non-uniformity	_
90-28	12333-12338	using	_
90-29	12339-12341	NU	_
90-30	12342-12351	intensity	_
90-31	12352-12362	correction	_
90-32	12363-12364	,	_
90-33	12365-12368	and	_
90-34	12369-12374	skull	_
90-35	12375-12383	stripped	_
90-36	12384-12389	using	_
90-37	12390-12391	a	_
90-38	12392-12401	watershed	_
90-39	12402-12411	algorithm	_
90-40	12412-12415	and	_
90-41	12416-12423	surface	_
90-42	12424-12435	deformation	_
90-43	12436-12443	process	_
90-44	12444-12445	.	_

91-1	12446-12450	Then	_
91-2	12451-12468	auto-segmentation	_
91-3	12469-12478	proceeded	_
91-4	12479-12483	with	_
91-5	12484-12490	labels	_
91-6	12491-12499	assigned	_
91-7	12500-12505	based	_
91-8	12506-12508	on	_
91-9	12509-12522	probabilistic	_
91-10	12523-12531	location	_
91-11	12532-12534	of	_
91-12	12535-12545	structures	_
91-13	12546-12547	.	_

92-1	12548-12550	10	_
92-2	12551-12552	%	_
92-3	12553-12555	of	_
92-4	12556-12570	auto-segmented	_
92-5	12571-12578	volumes	_
92-6	12579-12583	were	_
92-7	12584-12592	manually	_
92-8	12593-12600	checked	_
92-9	12601-12605	with	_
92-10	12606-12619	recon_checker	_
92-11	12620-12624	from	_
92-12	12625-12635	FreeSurfer	_
92-13	12636-12638	's	_
92-14	12639-12646	QATools	_
92-15	12647-12648	.	_

93-1	12649-12653	This	_
93-2	12654-12662	included	_
93-3	12663-12671	checking	_
93-4	12672-12675	for	_
93-5	12676-12684	outliers	_
93-6	12685-12686	,	_
93-7	12687-12698	calculating	_
93-8	12699-12714	signal-to-noise	_
93-9	12715-12720	ratio	_
93-10	12721-12722	,	_
93-11	12723-12726	and	_
93-12	12727-12735	visually	_
93-13	12736-12745	examining	_
93-14	12746-12755	generated	_
93-15	12756-12765	snapshots	_
93-16	12766-12768	of	_
93-17	12769-12774	brain	_
93-18	12775-12781	volume	_
93-19	12782-12794	segmentation	_
93-20	12795-12796	.	_

94-1	12797-12801	From	_
94-2	12802-12805	the	_
94-3	12806-12820	auto-segmented	_
94-4	12821-12828	regions	_
94-5	12829-12830	,	_
94-6	12831-12834	GMV	_
94-7	12835-12839	from	_
94-8	12840-12847	regions	_
94-9	12848-12850	of	_
94-10	12851-12859	interest	_
94-11	12860-12861	(	_
94-12	12862-12866	ROIs	_
94-13	12867-12868	)	_
94-14	12869-12873	were	_
94-15	12874-12882	selected	_
94-16	12883-12886	for	_
94-17	12887-12896	inclusion	_
94-18	12897-12899	in	_
94-19	12900-12903	the	_
94-20	12904-12912	analysis	_
94-21	12913-12918	based	_
94-22	12919-12921	on	_
94-23	12922-12930	previous	_
94-24	12931-12943	associations	_
94-25	12944-12948	with	_
94-26	12949-12952	AUD	_
94-27	12953-12959	within	_
94-28	12960-12968	selected	_
94-29	12969-12977	networks	_
94-30	12978-12980	of	_
94-31	12981-12989	interest	_
94-32	12990-12991	(	_
94-33	12992-12995	ECN	_
94-34	12996-12997	,	_
94-35	12998-13000	SN	_
94-36	13001-13002	,	_
94-37	13003-13006	DMN	_
94-38	13007-13008	,	_
94-39	13009-13014	basal	_
94-40	13015-13022	ganglia	_
94-41	13023-13024	)	_
94-42	13025-13026	:	_
94-43	13027-13030	the	_
94-44	13031-13039	amygdala	_
94-45	13040-13041	,	_
94-46	13042-13053	hippocampus	_
94-47	13054-13055	,	_
94-48	13056-13059	ACC	_
94-49	13060-13061	,	_
94-50	13062-13065	PCC	_
94-51	13066-13067	,	_
94-52	13068-13072	NAcc	_
94-53	13073-13074	,	_
94-54	13075-13077	GP	_
94-55	13078-13079	,	_
94-56	13080-13087	caudate	_
94-57	13088-13089	,	_
94-58	13090-13097	putamen	_
94-59	13098-13099	,	_
94-60	13100-13108	thalamus	_
94-61	13109-13110	,	_
94-62	13111-13121	cerebellum	_
94-63	13122-13123	,	_
94-64	13124-13127	OFC	_
94-65	13128-13129	,	_
94-66	13130-13133	SFG	_
94-67	13134-13135	,	_
94-68	13136-13139	MFG	_
94-69	13140-13141	,	_
94-70	13142-13145	TPJ	_
94-71	13146-13147	,	_
94-72	13148-13156	temporal	_
94-73	13157-13162	poles	_
94-74	13163-13164	,	_
94-75	13165-13173	anterior	_
94-76	13174-13180	insula	_
94-77	13181-13182	,	_
94-78	13183-13186	and	_
94-79	13187-13196	posterior	_
94-80	13197-13203	insula	_
94-81	13204-13205	.	_

95-1	13206-13211	Right	_
95-2	13212-13215	and	_
95-3	13216-13220	left	_
95-4	13221-13228	regions	_
95-5	13229-13233	were	_
95-6	13234-13243	extracted	_
95-7	13244-13254	separately	_
95-8	13255-13256	,	_
95-9	13257-13259	as	_
95-10	13260-13270	applicable	_
95-11	13271-13272	.	_

96-1	13273-13276	See	_
96-2	13277-13289	Supplemental	_
96-3	13290-13298	Material	_
96-4	13299-13300	2	_
96-5	13301-13304	for	_
96-6	13305-13313	unimodal	_
96-7	13314-13322	analysis	_
96-8	13323-13330	methods	_
96-9	13331-13334	and	_
96-10	13335-13342	results	_
96-11	13343-13344	.	_

97-1	13345-13354	Task-fMRI	_
97-2	13355-13359	data	_
97-3	13360-13363	was	_
97-4	13364-13372	analyzed	_
97-5	13373-13376	for	_
97-6	13377-13380	the	_
97-7	13381-13388	primary	_
97-8	13389-13393	data	_
97-9	13394-13397	set	_
97-10	13398-13402	only	_
97-11	13403-13408	using	_
97-12	13409-13421	multivariate	_
97-13	13422-13430	modeling	_
97-14	13431-13432	(	_
97-15	13433-13438	3dMVM	_
97-16	13439-13440	)	_
97-17	13441-13443	in	_
97-18	13444-13448	AFNI	_
97-19	13449-13450	.	_

98-1	13451-13456	First	_
98-2	13457-13458	,	_
98-3	13459-13464	masks	_
98-4	13465-13469	were	_
98-5	13470-13477	created	_
98-6	13478-13482	from	_
98-7	13483-13486	the	_
98-8	13487-13491	rest	_
98-9	13492-13495	ICs	_
98-10	13496-13505	described	_
98-11	13506-13511	above	_
98-12	13512-13513	(	_
98-13	13514-13517	see	_
98-14	13518-13521	Fig	_
98-15	13522-13523	.	_

99-1	13524-13526	2A	_
99-2	13527-13530	for	_
99-3	13531-13532	a	_
99-4	13533-13542	depiction	_
99-5	13543-13545	of	_
99-6	13546-13551	these	_
99-7	13552-13557	masks	_
99-8	13558-13559	)	_
99-9	13560-13561	.	_

100-1	13562-13566	Each	_
100-2	13567-13570	was	_
100-3	13571-13575	used	_
100-4	13576-13578	as	_
100-5	13579-13580	a	_
100-6	13581-13585	mask	_
100-7	13586-13588	in	_
100-8	13589-13590	6	_
100-9	13591-13599	separate	_
100-10	13600-13604	runs	_
100-11	13605-13607	of	_
100-12	13608-13613	3dMVM	_
100-13	13614-13615	.	_

101-1	13616-13619	For	_
101-2	13620-13624	each	_
101-3	13625-13629	mask	_
101-4	13630-13631	,	_
101-5	13632-13635	the	_
101-6	13636-13640	full	_
101-7	13641-13644	MVM	_
101-8	13645-13646	(	_
101-9	13647-13648	[	_
101-10	13649-13658	AUDIT+age	_
101-11	13659-13660	+	_
101-12	13661-13663	IQ	_
101-13	13664-13665	+	_
101-14	13666-13675	education	_
101-15	13676-13677	+	_
101-16	13678-13684	gender	_
101-17	13685-13686	]	_
101-18	13687-13688	*	_
101-19	13689-13698	condition	_
101-20	13699-13700	)	_
101-21	13701-13704	was	_
101-22	13705-13708	run	_
101-23	13709-13712	for	_
101-24	13713-13720	overall	_
101-25	13721-13733	significance	_
101-26	13734-13737	for	_
101-27	13738-13741	all	_
101-28	13742-13746	main	_
101-29	13747-13754	effects	_
101-30	13755-13758	and	_
101-31	13759-13771	interactions	_
101-32	13772-13773	.	_

102-1	13774-13778	Then	_
102-2	13779-13780	,	_
102-3	13781-13791	conditions	_
102-4	13792-13794	of	_
102-5	13795-13803	interest	_
102-6	13804-13808	were	_
102-7	13809-13816	modeled	_
102-8	13817-13822	using	_
102-9	13823-13830	general	_
102-10	13831-13837	linear	_
102-11	13838-13843	tests	_
102-12	13844-13847	and	_
102-13	13848-13855	related	_
102-14	13856-13858	to	_
102-15	13859-13864	AUDIT	_
102-16	13865-13870	score	_
102-17	13871-13872	.	_

103-1	13873-13876	For	_
103-2	13877-13880	the	_
103-3	13881-13884	MID	_
103-4	13885-13894	task-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
103-5	13895-13896	,	_
103-6	13897-13900	our	_
103-7	13901-13911	conditions	_
103-8	13912-13914	of	_
103-9	13915-13923	interest	_
103-10	13924-13928	were	_
103-11	13929-13935	Reward	_
103-12	13936-13948	Anticipation	_
103-13	13949-13950	(	_
103-14	13951-13955	High	_
103-15	13956-13962	Reward	_
103-16	13963-13964	–	_
103-17	13965-13972	Neutral	_
103-18	13973-13974	)	_
103-19	13975-13978	and	_
103-20	13979-13983	Loss	_
103-21	13984-13996	Anticipation	_
103-22	13997-13998	(	_
103-23	13999-14003	High	_
103-24	14004-14008	Loss	_
103-25	14009-14010	–	_
103-26	14011-14018	Neutral	_
103-27	14019-14020	)	_
103-28	14021-14022	.	_

104-1	14023-14033	Percentage	_
104-2	14034-14036	of	_
104-3	14037-14041	hits	_
104-4	14042-14045	for	_
104-5	14046-14052	reward	_
104-6	14053-14056	and	_
104-7	14057-14061	loss	_
104-8	14062-14066	cued	_
104-9	14067-14074	targets	_
104-10	14075-14078	was	_
104-11	14079-14087	examined	_
104-12	14088-14100	behaviorally	_
104-13	14101-14102	.	_

105-1	14103-14105	In	_
105-2	14106-14109	the	_
105-3	14110-14114	Face	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
105-4	14115-14123	Matching	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
105-5	14124-14133	task-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
105-6	14134-14135	,	_
105-7	14136-14139	our	_
105-8	14140-14149	condition	_
105-9	14150-14152	of	_
105-10	14153-14161	interest	_
105-11	14162-14165	was	_
105-12	14166-14174	Negative	_
105-13	14175-14184	Emotional	_
105-14	14185-14189	Face	_
105-15	14190-14200	Processing	_
105-16	14201-14202	(	_
105-17	14203-14204	[	_
105-18	14205-14210	Angry	_
105-19	14211-14216	Faces	_
105-20	14217-14218	+	_
105-21	14219-14222	Sad	_
105-22	14223-14228	Faces	_
105-23	14229-14230	+	_
105-24	14231-14238	Fearful	_
105-25	14239-14244	Faces	_
105-26	14245-14246	]	_
105-27	14247-14249	/3	_
105-28	14250-14251	–	_
105-29	14252-14259	Neutral	_
105-30	14260-14265	Faces	_
105-31	14266-14267	)	_
105-32	14268-14269	.	_

106-1	14270-14273	See	_
106-2	14274-14286	Supplemental	_
106-3	14287-14295	Material	_
106-4	14296-14297	3	_
106-5	14298-14301	for	_
106-6	14302-14309	results	_
106-7	14310-14314	from	_
106-8	14315-14320	these	_
106-9	14321-14329	unimodal	_
106-10	14330-14338	analyses	_
106-11	14339-14340	.	_

107-1	14341-14343	We	_
107-2	14344-14348	then	_
107-3	14349-14353	used	_
107-4	14354-14355	a	_
107-5	14356-14363	machine	_
107-6	14364-14372	learning	_
107-7	14373-14382	procedure	_
107-8	14383-14390	trained	_
107-9	14391-14393	in	_
107-10	14394-14395	a	_
107-11	14396-14405	subsample	_
107-12	14406-14408	of	_
107-13	14409-14412	our	_
107-14	14413-14421	subjects	_
107-15	14422-14424	to	_
107-16	14425-14432	predict	_
107-17	14433-14438	AUDIT	_
107-18	14439-14444	score	_
107-19	14445-14450	based	_
107-20	14451-14453	on	_
107-21	14454-14460	neural	_
107-22	14461-14469	features	_
107-23	14470-14471	.	_

108-1	14472-14475	The	_
108-2	14476-14482	inputs	_
108-3	14483-14485	to	_
108-4	14486-14491	these	_
108-5	14492-14500	learning	_
108-6	14501-14507	models	_
108-7	14508-14512	were	_
108-8	14513-14519	neural	_
108-9	14520-14528	features	_
108-10	14529-14538	extracted	_
108-11	14539-14543	from	_
108-12	14544-14547	the	_
108-13	14548-14555	rs-fMRI	_
108-14	14556-14557	,	_
108-15	14558-14567	task-fMRI	_
108-16	14568-14569	,	_
108-17	14570-14573	and	_
108-18	14574-14578	sMRI	_
108-19	14579-14587	analyses	_
108-20	14588-14589	.	_

109-1	14590-14593	For	_
109-2	14594-14601	rs-fMRI	_
109-3	14602-14603	,	_
109-4	14604-14608	beta	_
109-5	14609-14621	coefficients	_
109-6	14622-14628	within	_
109-7	14629-14630	5	_
109-8	14631-14633	mm	_
109-9	14634-14640	radius	_
109-10	14641-14648	spheres	_
109-11	14649-14651	of	_
109-12	14652-14661	locations	_
109-13	14662-14664	in	_
109-14	14665-14668	ICs	_
109-15	14669-14676	related	_
109-16	14677-14679	to	_
109-17	14680-14685	AUDIT	_
109-18	14686-14687	(	_
109-19	14688-14693	based	_
109-20	14694-14696	on	_
109-21	14697-14700	the	_
109-22	14701-14708	primary	_
109-23	14709-14715	sample	_
109-24	14716-14720	only	_
109-25	14721-14722	)	_
109-26	14723-14727	were	_
109-27	14728-14737	extracted	_
109-28	14738-14741	and	_
109-29	14742-14750	included	_
109-30	14751-14753	as	_
109-31	14754-14768	within-network	_
109-32	14769-14781	connectivity	_
109-33	14782-14790	features	_
109-34	14791-14792	.	_

110-1	14793-14796	FNC	_
110-2	14797-14809	connectivity	_
110-3	14810-14818	matrices	_
110-4	14819-14822	for	_
110-5	14823-14827	each	_
110-6	14828-14835	subject	_
110-7	14836-14840	were	_
110-8	14841-14845	also	_
110-9	14846-14854	included	_
110-10	14855-14857	as	_
110-11	14858-14873	between-network	_
110-12	14874-14886	connectivity	_
110-13	14887-14895	features	_
110-14	14896-14897	.	_

111-1	14898-14901	For	_
111-2	14902-14911	task-fMRI	_
111-3	14912-14916	data	_
111-4	14917-14918	,	_
111-5	14919-14923	peak	_
111-6	14924-14928	beta	_
111-7	14929-14941	coefficients	_
111-8	14942-14948	within	_
111-9	14949-14950	5	_
111-10	14951-14953	mm	_
111-11	14954-14960	radius	_
111-12	14961-14968	spheres	_
111-13	14969-14971	of	_
111-14	14972-14981	locations	_
111-15	14982-14984	of	_
111-16	14985-14990	AUDIT	_
111-17	14991-14992	*	_
111-18	14993-15002	condition	_
111-19	15003-15010	effects	_
111-20	15011-15012	(	_
111-21	15013-15020	defined	_
111-22	15021-15026	based	_
111-23	15027-15029	on	_
111-24	15030-15037	primary	_
111-25	15038-15044	sample	_
111-26	15045-15049	only	_
111-27	15050-15051	)	_
111-28	15052-15054	at	_
111-29	15055-15056	a	_
111-30	15057-15066	per-voxel	_
111-31	15067-15074	p-value	_
111-32	15075-15084	threshold	_
111-33	15085-15087	of	_
111-34	15088-15089	p	_
111-35	15090-15091	=	_
111-36	15092-15095	.05	_
111-37	15096-15100	were	_
111-38	15101-15110	extracted	_
111-39	15111-15114	and	_
111-40	15115-15123	included	_
111-41	15124-15126	as	_
111-42	15127-15136	task-fMRI	_
111-43	15137-15145	features	_
111-44	15146-15147	.	_

112-1	15148-15151	The	_
112-2	15152-15169	beta-coefficients	_
112-3	15170-15174	were	_
112-4	15175-15179	also	_
112-5	15180-15189	extracted	_
112-6	15190-15192	at	_
112-7	15193-15198	these	_
112-8	15199-15208	locations	_
112-9	15209-15211	in	_
112-10	15212-15215	the	_
112-11	15216-15226	validation	_
112-12	15227-15233	sample	_
112-13	15234-15235	.	_

113-1	15236-15240	This	_
113-2	15241-15252	uncorrected	_
113-3	15253-15260	p-value	_
113-4	15261-15264	was	_
113-5	15265-15269	used	_
113-6	15270-15273	for	_
113-7	15274-15281	feature	_
113-8	15282-15291	selection	_
113-9	15292-15296	only	_
113-10	15297-15298	,	_
113-11	15299-15302	not	_
113-12	15303-15306	for	_
113-13	15307-15317	evaluation	_
113-14	15318-15320	of	_
113-15	15321-15332	statistical	_
113-16	15333-15345	significance	_
113-17	15346-15347	.	_

114-1	15348-15358	Behavioral	_
114-2	15359-15363	data	_
114-3	15364-15367	was	_
114-4	15368-15371	not	_
114-5	15372-15380	included	_
114-6	15381-15388	because	_
114-7	15389-15394	there	_
114-8	15395-15398	was	_
114-9	15399-15402	not	_
114-10	15403-15404	a	_
114-11	15405-15416	significant	_
114-12	15417-15428	correlation	_
114-13	15429-15436	between	_
114-14	15437-15442	AUDIT	_
114-15	15443-15446	and	_
114-16	15447-15450	hit	_
114-17	15451-15462	percentages	_
114-18	15463-15466	for	_
114-19	15467-15473	reward	_
114-20	15474-15476	or	_
114-21	15477-15481	loss	_
114-22	15482-15486	cued	_
114-23	15487-15494	targets	_
114-24	15495-15497	in	_
114-25	15498-15501	the	_
114-26	15502-15509	primary	_
114-27	15510-15516	sample	_
114-28	15517-15518	.	_

115-1	15519-15522	For	_
115-2	15523-15527	sMRI	_
115-3	15528-15532	data	_
115-4	15533-15534	,	_
115-5	15535-15542	volumes	_
115-6	15543-15545	of	_
115-7	15546-15550	ROIs	_
115-8	15551-15552	,	_
115-9	15553-15562	described	_
115-10	15563-15565	in	_
115-11	15566-15569	the	_
115-12	15570-15579	preceding	_
115-13	15580-15589	paragraph	_
115-14	15590-15591	,	_
115-15	15592-15596	were	_
115-16	15597-15605	included	_
115-17	15606-15608	as	_
115-18	15609-15617	features	_
115-19	15618-15619	.	_

116-1	15620-15623	The	_
116-2	15624-15631	overlap	_
116-3	15632-15639	between	_
116-4	15640-15645	these	_
116-5	15646-15654	features	_
116-6	15655-15658	was	_
116-7	15659-15668	evaluated	_
116-8	15669-15682	qualitatively	_
116-9	15683-15684	.	_

117-1	15685-15691	Within	_
117-2	15692-15695	the	_
117-3	15696-15703	initial	_
117-4	15704-15710	sample	_
117-5	15711-15715	that	_
117-6	15716-15719	had	_
117-7	15720-15724	data	_
117-8	15725-15728	for	_
117-9	15729-15732	all	_
117-10	15733-15737	fMRI	_
117-11	15738-15741	and	_
117-12	15742-15746	sMRI	_
117-13	15747-15752	scans	_
117-14	15753-15754	(	_
117-15	15755-15756	n	_
117-16	15757-15758	=	_
117-17	15759-15761	44	_
117-18	15762-15763	)	_
117-19	15764-15765	,	_
117-20	15766-15768	we	_
117-21	15769-15773	used	_
117-22	15774-15776	10	_
117-23	15777-15784	repeats	_
117-24	15785-15787	of	_
117-25	15788-15789	a	_
117-26	15790-15797	10-fold	_
117-27	15798-15803	cross	_
117-28	15804-15814	validation	_
117-29	15815-15824	procedure	_
117-30	15825-15827	to	_
117-31	15828-15833	train	_
117-32	15834-15835	a	_
117-33	15836-15840	fast	_
117-34	15841-15855	implementation	_
117-35	15856-15862	random	_
117-36	15863-15869	forest	_
117-37	15870-15880	regression	_
117-38	15881-15885	tree	_
117-39	15886-15891	model	_
117-40	15892-15899	through	_
117-41	15900-15903	the	_
117-42	15904-15905	‘	_
117-43	15906-15912	ranger	_
117-44	15913-15914	’	_
117-45	15915-15921	method	_
117-46	15922-15927	using	_
117-47	15928-15931	the	_
117-48	15932-15937	caret	_
117-49	15938-15945	package	_
117-50	15946-15948	in	_
117-51	15949-15951	R.	_
117-52	15952-15956	This	_
117-53	15957-15962	model	_
117-54	15963-15972	generated	_
117-55	15973-15976	500	_
117-56	15977-15982	trees	_
117-57	15983-15986	and	_
117-58	15987-15990	was	_
117-59	15991-15996	tuned	_
117-60	15997-15998	(	_
117-61	15999-16009	tunelength	_
117-62	16010-16011	=	_
117-63	16012-16014	10	_
117-64	16015-16016	)	_
117-65	16017-16019	in	_
117-66	16020-16024	each	_
117-67	16025-16034	iteration	_
117-68	16035-16041	across	_
117-69	16042-16048	number	_
117-70	16049-16051	of	_
117-71	16052-16060	randomly	_
117-72	16061-16069	selected	_
117-73	16070-16080	predictors	_
117-74	16081-16082	,	_
117-75	16083-16087	tree	_
117-76	16088-16093	split	_
117-77	16094-16098	rule	_
117-78	16099-16100	(	_
117-79	16101-16109	variance	_
117-80	16110-16112	or	_
117-81	16113-16118	extra	_
117-82	16119-16124	trees	_
117-83	16125-16126	)	_
117-84	16127-16128	,	_
117-85	16129-16132	and	_
117-86	16133-16140	minimum	_
117-87	16141-16145	node	_
117-88	16146-16150	size	_
117-89	16151-16152	;	_
117-90	16153-16155	by	_
117-91	16156-16163	default	_
117-92	16164-16165	,	_
117-93	16166-16173	maximum	_
117-94	16174-16178	tree	_
117-95	16179-16184	depth	_
117-96	16185-16188	was	_
117-97	16189-16192	set	_
117-98	16193-16195	to	_
117-99	16196-16205	unlimited	_
117-100	16206-16211	while	_
117-101	16212-16217	other	_
117-102	16218-16225	options	_
117-103	16226-16227	(	_
117-104	16228-16239	probability	_
117-105	16240-16241	,	_
117-106	16242-16249	replace	_
117-107	16250-16251	,	_
117-108	16252-16280	scale.permutation.importance	_
117-109	16281-16282	,	_
117-110	16283-16293	keep.inbag	_
117-111	16294-16295	,	_
117-112	16296-16304	houldout	_
117-113	16305-16306	,	_
117-114	16307-16315	quantreg	_
117-115	16316-16317	,	_
117-116	16318-16329	save.memory	_
117-117	16330-16331	)	_
117-118	16332-16335	are	_
117-119	16336-16339	set	_
117-120	16340-16342	to	_
117-121	16343-16348	FALSE	_
117-122	16349-16350	.	_

118-1	16351-16358	Feature	_
118-2	16359-16369	importance	_
118-3	16370-16373	was	_
118-4	16374-16383	evaluated	_
118-5	16384-16389	using	_
118-6	16390-16392	an	_
118-7	16393-16401	impurity	_
118-8	16402-16409	measure	_
118-9	16410-16415	based	_
118-10	16416-16418	on	_
118-11	16419-16431	standardized	_
118-12	16432-16440	response	_
118-13	16441-16449	variance	_
118-14	16450-16452	in	_
118-15	16453-16463	prediction	_
118-16	16464-16466	of	_
118-17	16467-16472	AUDIT	_
118-18	16473-16479	across	_
118-19	16480-16485	trees	_
118-20	16486-16487	.	_

119-1	16488-16492	This	_
119-2	16493-16500	feature	_
119-3	16501-16511	importance	_
119-4	16512-16515	was	_
119-5	16516-16520	then	_
119-6	16521-16531	normalized	_
119-7	16532-16536	such	_
119-8	16537-16541	that	_
119-9	16542-16545	the	_
119-10	16546-16553	feature	_
119-11	16554-16558	with	_
119-12	16559-16562	the	_
119-13	16563-16570	maximum	_
119-14	16571-16581	importance	_
119-15	16582-16584	is	_
119-16	16585-16591	scaled	_
119-17	16592-16594	to	_
119-18	16595-16598	100	_
119-19	16599-16600	.	_

120-1	16601-16604	The	_
120-2	16605-16612	optimum	_
120-3	16613-16618	model	_
120-4	16619-16622	was	_
120-5	16623-16631	selected	_
120-6	16632-16637	based	_
120-7	16638-16640	on	_
120-8	16641-16651	minimizing	_
120-9	16652-16668	Root-Mean-Square	_
120-10	16669-16674	Error	_
120-11	16675-16676	(	_
120-12	16677-16681	RMSE	_
120-13	16682-16683	)	_
120-14	16684-16685	.	_

121-1	16686-16688	We	_
121-2	16689-16693	also	_
121-3	16694-16700	report	_
121-4	16701-16703	R2	_
121-5	16704-16706	as	_
121-6	16707-16708	a	_
121-7	16709-16717	goodness	_
121-8	16718-16720	of	_
121-9	16721-16724	fit	_
121-10	16725-16732	measure	_
121-11	16733-16734	(	_
121-12	16735-16745	calculated	_
121-13	16746-16748	as	_
121-14	16749-16752	the	_
121-15	16753-16760	squared	_
121-16	16761-16772	correlation	_
121-17	16773-16780	between	_
121-18	16781-16784	the	_
121-19	16785-16794	predicted	_
121-20	16795-16798	and	_
121-21	16799-16807	observed	_
121-22	16808-16813	AUDIT	_
121-23	16814-16820	scores	_
121-24	16821-16822	)	_
121-25	16823-16824	.	_

122-1	16825-16828	The	_
122-2	16829-16841	significance	_
122-3	16842-16844	of	_
122-4	16845-16848	the	_
122-5	16849-16851	R2	_
122-6	16852-16858	values	_
122-7	16859-16862	was	_
122-8	16863-16872	evaluated	_
122-9	16873-16878	using	_
122-10	16879-16880	a	_
122-11	16881-16892	permutation	_
122-12	16893-16900	testing	_
122-13	16901-16910	procedure	_
122-14	16911-16913	in	_
122-15	16914-16919	which	_
122-16	16920-16922	we	_
122-17	16923-16930	compare	_
122-18	16931-16934	the	_
122-19	16935-16943	observed	_
122-20	16944-16946	R2	_
122-21	16947-16951	with	_
122-22	16952-16953	a	_
122-23	16954-16966	distribution	_
122-24	16967-16969	of	_
122-25	16970-16972	R2	_
122-26	16973-16979	values	_
122-27	16980-16989	generated	_
122-28	16990-16995	based	_
122-29	16996-16998	on	_
122-30	16999-17003	2000	_
122-31	17004-17010	random	_
122-32	17011-17023	permutations	_
122-33	17024-17026	of	_
122-34	17027-17030	the	_
122-35	17031-17037	sample	_
122-36	17038-17042	data	_
122-37	17043-17044	.	_

123-1	17045-17048	The	_
123-2	17049-17055	number	_
123-3	17056-17058	of	_
123-4	17059-17068	simulated	_
123-5	17069-17071	R2	_
123-6	17072-17078	values	_
123-7	17079-17083	that	_
123-8	17084-17088	were	_
123-9	17089-17091	as	_
123-10	17092-17094	or	_
123-11	17095-17099	more	_
123-12	17100-17107	extreme	_
123-13	17108-17112	than	_
123-14	17113-17116	the	_
123-15	17117-17125	observed	_
123-16	17126-17128	R2	_
123-17	17129-17132	was	_
123-18	17133-17140	divided	_
123-19	17141-17143	by	_
123-20	17144-17147	the	_
123-21	17148-17154	number	_
123-22	17155-17157	of	_
123-23	17158-17169	simulations	_
123-24	17170-17172	to	_
123-25	17173-17180	produce	_
123-26	17181-17182	a	_
123-27	17183-17190	p-value	_
123-28	17191-17194	for	_
123-29	17195-17206	determining	_
123-30	17207-17219	significance	_
123-31	17220-17221	.	_

124-1	17222-17226	Then	_
124-2	17227-17228	,	_
124-3	17229-17232	the	_
124-4	17233-17241	capacity	_
124-5	17242-17244	of	_
124-6	17245-17249	that	_
124-7	17250-17255	model	_
124-8	17256-17258	to	_
124-9	17259-17269	generalize	_
124-10	17270-17273	was	_
124-11	17274-17280	tested	_
124-12	17281-17286	using	_
124-13	17287-17290	the	_
124-14	17291-17301	validation	_
124-15	17302-17306	data	_
124-16	17307-17310	set	_
124-17	17311-17312	(	_
124-18	17313-17314	n	_
124-19	17315-17316	=	_
124-20	17317-17319	24	_
124-21	17320-17321	)	_
124-22	17322-17323	,	_
124-23	17324-17329	which	_
124-24	17330-17333	was	_
124-25	17334-17337	not	_
124-26	17338-17342	used	_
124-27	17343-17345	in	_
124-28	17346-17349	any	_
124-29	17350-17353	way	_
124-30	17354-17356	to	_
124-31	17357-17366	determine	_
124-32	17367-17372	which	_
124-33	17373-17381	features	_
124-34	17382-17386	were	_
124-35	17387-17395	included	_
124-36	17396-17398	in	_
124-37	17399-17402	the	_
124-38	17403-17409	models	_
124-39	17410-17411	,	_
124-40	17412-17421	providing	_
124-41	17422-17424	us	_
124-42	17425-17427	an	_
124-43	17428-17436	estimate	_
124-44	17437-17439	of	_
124-45	17440-17443	the	_
124-46	17444-17448	true	_
124-47	17449-17454	error	_
124-48	17455-17458	and	_
124-49	17459-17470	performance	_
124-50	17471-17473	of	_
124-51	17474-17477	the	_
124-52	17478-17483	model	_
124-53	17484-17485	.	_

125-1	17486-17490	This	_
125-2	17491-17501	procedures	_
125-3	17502-17509	follows	_
125-4	17510-17525	recommendations	_
125-5	17526-17528	by	_
125-6	17529-17530	.	_

126-1	17531-17542	Demographic	_
126-2	17543-17551	features	_
126-3	17552-17560	included	_
126-4	17561-17565	were	_
126-5	17566-17569	age	_
126-6	17570-17571	,	_
126-7	17572-17574	IQ	_
126-8	17575-17576	,	_
126-9	17577-17582	years	_
126-10	17583-17585	of	_
126-11	17586-17595	education	_
126-12	17596-17597	,	_
126-13	17598-17601	and	_
126-14	17602-17608	gender	_
126-15	17609-17610	;	_
126-16	17611-17613	we	_
126-17	17614-17622	selected	_
126-18	17623-17628	these	_
126-19	17629-17637	features	_
126-20	17638-17640	to	_
126-21	17641-17646	serve	_
126-22	17647-17649	as	_
126-23	17650-17651	a	_
126-24	17652-17660	baseline	_
126-25	17661-17671	comparison	_
126-26	17672-17677	model	_
126-27	17678-17680	to	_
126-28	17681-17684	aid	_
126-29	17685-17687	in	_
126-30	17688-17701	understanding	_
126-31	17702-17705	the	_
126-32	17706-17713	utility	_
126-33	17714-17716	of	_
126-34	17717-17720	the	_
126-35	17721-17733	neuroimaging	_
126-36	17734-17741	feature	_
126-37	17742-17746	sets	_
126-38	17747-17752	above	_
126-39	17753-17761	features	_
126-40	17762-17766	that	_
126-41	17767-17772	could	_
126-42	17773-17775	be	_
126-43	17776-17780	more	_
126-44	17781-17787	easily	_
126-45	17788-17791	and	_
126-46	17792-17802	affordably	_
126-47	17803-17812	collected	_
126-48	17813-17815	in	_
126-49	17816-17823	primary	_
126-50	17824-17828	care	_
126-51	17829-17831	or	_
126-52	17832-17840	hospital	_
126-53	17841-17849	settings	_
126-54	17850-17851	.	_

127-1	17852-17854	In	_
127-2	17855-17860	order	_
127-3	17861-17863	to	_
127-4	17864-17872	evaluate	_
127-5	17873-17876	the	_
127-6	17877-17885	relative	_
127-7	17886-17897	performance	_
127-8	17898-17900	of	_
127-9	17901-17908	rs-fMRI	_
127-10	17909-17910	,	_
127-11	17911-17920	task-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
127-12	17921-17922	,	_
127-13	17923-17927	sMRI	_
127-14	17928-17929	,	_
127-15	17930-17933	and	_
127-16	17934-17945	demographic	_
127-17	17946-17954	features	_
127-18	17955-17956	,	_
127-19	17957-17961	five	_
127-20	17962-17970	versions	_
127-21	17971-17973	of	_
127-22	17974-17979	these	_
127-23	17980-17986	models	_
127-24	17987-17991	were	_
127-25	17992-17999	trained	_
127-26	18000-18001	,	_
127-27	18002-18008	tested	_
127-28	18009-18010	,	_
127-29	18011-18014	and	_
127-30	18015-18019	then	_
127-31	18020-18028	compared	_
127-32	18029-18030	:	_
127-33	18031-18034	all	_
127-34	18035-18041	neural	_
127-35	18042-18050	features	_
127-36	18051-18053	in	_
127-37	18054-18065	combination	_
127-38	18066-18067	(	_
127-39	18068-18069	#	_
127-40	18070-18078	features	_
127-41	18079-18080	=	_
127-42	18081-18085	5653	_
127-43	18086-18087	)	_
127-44	18088-18089	,	_
127-45	18090-18094	just	_
127-46	18095-18102	rs-fMRI	_
127-47	18103-18111	features	_
127-48	18112-18113	(	_
127-49	18114-18115	#	_
127-50	18116-18124	features	_
127-51	18125-18126	=	_
127-52	18127-18130	922	_
127-53	18131-18132	)	_
127-54	18133-18134	,	_
127-55	18135-18139	just	_
127-56	18140-18149	task-fMRI	_
127-57	18150-18158	features	_
127-58	18159-18160	(	_
127-59	18161-18162	#	_
127-60	18163-18171	features	_
127-61	18172-18173	=	_
127-62	18174-18178	4699	_
127-63	18179-18180	)	_
127-64	18181-18182	,	_
127-65	18183-18187	just	_
127-66	18188-18192	sMRI	_
127-67	18193-18201	features	_
127-68	18202-18203	(	_
127-69	18204-18205	#	_
127-70	18206-18214	features	_
127-71	18215-18216	=	_
127-72	18217-18219	32	_
127-73	18220-18221	)	_
127-74	18222-18223	,	_
127-75	18224-18227	and	_
127-76	18228-18232	just	_
127-77	18233-18244	demographic	_
127-78	18245-18253	features	_
127-79	18254-18255	(	_
127-80	18256-18257	#	_
127-81	18258-18266	features	_
127-82	18267-18268	=	_
127-83	18269-18270	4	_
127-84	18271-18272	)	_
127-85	18273-18274	.	_

